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ABSTRACT 
Exercise-induced neuroprotection in a hemiparkinsonian 6-hydroxydopamine rat model 
 
by 
 
Merrill Russen Landers 
 
 
Dr. Frank van Breukelen, Examination Committee Chair 
Associate Professor of Biology 
University of Nevada, Las Vegas 
 
 
Outside of finding a cure, one of the preeminent goals of research in Parkinson’s 
disease (PD) is finding a neuroprotective treatment that when applied prior to the onset 
of the disease will decrease the risk and severity of the subsequent disease.  One such 
treatment that has potential as a neuroprotective agent in PD is exercise.  Several 
studies have found forced exercise to be protective of Parkinson’s disease in adult 
rodent models; however, few of these studies have used a design wherein voluntary 
exercise was evaluated.  Moreover, no study has used a true neuroprotective design in 
which exercise was applied prior to disease onset and throughout the life of the animal.  
Therefore, the focus of this dissertation was to further explore the role of a 
preconditioning of exercise, both forced and voluntary, in a 6-hydroxydopamine-
induced hemiparkinsonian rat model.  The research approach adopted in this 
dissertation included a randomized control design of forced and voluntary exercise (i.e., 
treadmill and running wheel) applied before and after neurotoxin-induced 
hemiparkinsonism.  Motor behavior tests were used to assess the outcomes.  The 
findings from this dissertation provide evidence that exercise, either forced or 
iv 
 
voluntary, does not provide any neuroprotective benefit in terms of protection from 
Parkinsonian motor signs and forelimb asymmetry.  The collective results of this 
dissertation cast doubt on the current body of the literature on exercise 
neuroprotection in PD and suggest that the notion that exercise is neuroprotective is 
premature. 
 
Keywords:  voluntary, forced, exercise, neuroplasticity, Parkinson’s disease, dopamine, 
stress 
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CHAPTER 1 
 
Parkinson’s disease 
Parkinson’s disease (PD), named after the first clinical description by James 
Parkinson in 1817, is the most common movement disorder and the second most 
common neurodegenerative disease after Alzheimer’s disease (Fahn & Sulzer, 2004).  
The age-adjusted annual incidence in the US between the ages of 50 and 99 is 114.7 
cases per 100,000 and steeply increases as one ages (Bower et al., 1999).  Since PD is 
more common with increasing age, its prevalence is expected to triple over the next 50 
years due to the aging US population.   
PD manifests typically in the sixth decade of life and begins with relatively 
modest limitations that progressively cause disability over the next few decades.  PD is 
characterized by four slowly progressive cardinal signs: bradykinesia (slowness of 
movement), rigidity (stiffness), resting tremor, and postural instability (balance 
impairment).  The cumulative effects of these impairments are often very troubling and 
can lead to considerable disability.  While the motor deficits associated with PD are not 
usually directly life threatening, they contribute to falling which in turn can lead to 
severe injuries (e.g., head injuries, fractures, etc.) and hospitalization.  Eventually those 
with PD may be confined to a wheelchair and may socially isolate themselves from their 
regular activities, which stimulates a vicious cycle of decreased physical conditioning 
and subsequent increased potential for aspiration pneumonia and falling, which are the 
most common causes of mortality in PD.  Not surprisingly, patients with PD have an 
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increased risk of death as compared to age and gender matched persons (Uitti et al., 
1993).  Studies have demonstrated a two to three-fold risk for death in PD as compared 
to those without PD, which corresponded to an 8 year decrease in life expectancy 
(Morens et al., 1996). 
Treatment has not been directed at the causative agent of PD because it is 
unknown.  Therefore, most treatment has focused on ameliorating the symptoms of the 
PD.  Unfortunately, these treatment strategies do not stop the progressive degenerative 
nature of the disease.  Treatment is typically classified into three main categories: 
nonpharmacologic, pharmacologic, and surgical.  There is no single approach to the 
management of PD; however, the most acceptable approach is pharmacologic therapy 
using one or more of the following classes of medications: dopamine precursors 
(levodopa), dopamine agonists, anticholinergics, catechol-O-methyl tranferase inhibitors 
(blocks dopamine metabolism), monoamine oxidase B inhibitors (blocks central 
dopamine metabolism), and amantadine.   
The most effective pharmacologic treatment for PD, levodopa, has a limited 
period of effectiveness (7-12 years) and is associated with irreversible dyskinesias and 
motor fluctuations (Poewe et al., 1986; Schrag & Quinn, 2000).  Moreover, it is theorized 
that its oxidative metabolites may cause free radical formation which theoretically 
potentiate the neurodegeneration (Galvin, 2006; Hastings & Zigmond, 1997; J. Xu et al., 
2002; Yu et al., 2005).  Because of these reasons, it is generally not given as a first line 
therapy even though it is the most effective at reducing the symptoms.  Most patients 
typically begin with dopamine agonists and usually one or more of the other 
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medications as adjuncts.  Because of the monoamine oxidase B inhibitor Deprenyl has 
demonstrated a neuroprotective delay of disease onset by 9 months, it has become an 
attractive neuroprotective agent (LeWitt, 1991).  Unfortunately, no long term positive 
effects have been demonstrated so the neuroprotective ability of the drug has been a 
source of contention in the literature (Shoulson, 1998). 
Aside from the continual search for the neuropathologic etiology of PD and 
treatment efficacy studies, attention on neuroprotective strategies in PD has gained 
considerable traction (Biglan & Ravina, 2007; Fahn & Sulzer, 2004; Hauser & Zesiewicz, 
2006; Kieburtz, 2006; LeWitt, 2004, 2006; Poewe, 2006; Simpkins & Jankovic, 2003) with 
as many as 59 potential neuroprotective therapies in various stages of investigation 
(Ravina et al., 2003).  Some of these putative neuroprotective strategies range from 
pharmacologic agents, like pramipexole (Joyce et al., 2004) and Ropinirole (Whone et 
al., 2003), to behavioral manipulations like smoking (Papapetropoulos et al., 2005) and 
dietary restriction (Mattson et al., 2004).  It is hoped that these neuroprotective 
strategies will eventually either prevent the disease for those at risk, increase the age of 
disease onset for those at risk, decrease the severity of disease at onset, and/or slow 
the rate of disease progression once the disease has been acquired.  
 
Etiopathogenesis 
PD is characterized by the progressive loss of dopamine producing cells in the 
substantia nigra of the midbrain.  These dopaminergic neurons project to the basal 
ganglia where they release their dopamine into the striatum of the basal ganglia.  This is 
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commonly referred to as the nigrostriatal pathway.  It is the paucity of dopamine in the 
striatum secondary to nigrostriatal attrition that causes the imbalance of motor 
facilitation and inhibition resulting in the characteristic features of the disease.  Despite 
considerable research, it is not known what the etiological trigger of the disease is; 
hence, it is commonly referred to as “idiopathic.” 
The current etiological theory is that an unknown environmental toxin or toxins 
act on genetically susceptible individuals to cause the disease.  Unfortunately, the 
environmental toxin or toxins remain elusive.  In addition, there are only a small 
minority of cases that have a known genetic cause.  Currently, there are thirteen 
different familial types of PD (Table 1) representing a small minority of the cases of PD 
(Abeliovich & Flint Beal, 2006).  While the link between the environmental toxin and the 
genetic susceptibility lacks direct evidence, it represents the leading etiological theory 
for the disease. 
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Table 1.  Known genetic causes of PD (Biskup et al., 2008; Gasser, 2005, 2007). 
 
Locus Inheritance Gene Gene product 
Map 
position Comments 
PARK1 Dominant SNCA α-synuclein 4q21 First identified, 3 point 
mutations have been 
found 
PARK2 Recessive Parkin 465 RING finger 
protein, a 
ubiquitin E3 
ligase 
6q25 Most common cause of 
early onset PD (18%) 
PARK3 Dominant SPR? ? 2p13  
PARK4 Dominant α-synuclein α-synuclein 
triplications 
duplications 
4q21 Excessive α-synuclein 
PARK5 Dominant UCH L1 Ubiquitin C-
terminal 
hydroxylase L1 
4p14  
PARK6 Recessive PINK1 PTEN-induced 
putative kinase 
1 
1p35-37 Second most common 
cause of early onset PD 
PARK7 Recessive DJ-1 DJ-1 1p38 DJ-1 knockdown leads 
to oxidative stress 
susceptibility 
PARK8 Dominant LRRK2 (leucine 
rich repeat 
kinase 2) 
Dardarin 12 cen Most common genetic 
cause of PD (1-6% of US 
and Euro PD studies; 
29.7% of PD in 
Ashkenazi Jews) 
PARK9 AR ATP13A2 ? 1p36  
PARK10 Dominant? ? ? 1p32  
PARK11 Dominant? GIGYF2? ? 2q34  
PARK12 X-linked ? ? Zq21  
PARK13 Dominant? OMI/HTRA2 Serine protease 2p12  
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The progressive loss of the dopaminergic nigrostriatal neurons in PD underlies 
the disease pathogenesis.  What triggers this progressive neurodegeneration is not 
currently known.  However, research suggests that α-synuclein, an intrinsically 
unstructured, presynaptic terminal protein, plays a prominent role (Eriksen et al., 2003; 
Goedert, 2001).  α-synuclein binds to fatty acids and is thought to play a role as a 
molecular chaperone and as a regulator of dopaminergic synaptic vesicles (Dev et al., 
2003).  α-synuclein is also theorized to play a role in the filling and refilling of 
dopaminergic synaptic vesicles (Abeliovich et al., 2000) and in support of this notion has 
been shown to be  closely associated with synaptic vesicles through 
immunohistochemistry (Clayton & George, 1999).  Interestingly, absence or inactivation 
of α-synuclein in mice models produces only mild, benign behavioral changes (Dev et al., 
2003; Goedert, 2001). 
Aggregations of α-synuclein are found in cytoplasmic inclusions of affected 
nigrostriatal neurons in those with PD; these inclusions are called Lewy bodies and Lewy 
neurites.  These Lewy bodies and neuritis are considered the pathological hallmark of 
the disease (Figure 1).  The presence of these inclusion bodies in nigrostriatal neuron 
soma (Lewy bodies) and axons/dendrites (Lewy neuritis) is highly characteristic of the 
disease.  There are other diseases that also have Lewy body inclusions (e.g., diffuse 
Lewy body disease, dementia with Lewy bodies); however, these are found in different 
brain regions. 
Lewy bodies and Lewy neurites contain high quantities of misfolded and 
aggregated α-synuclein, a molecular chaperone, and another protein, ubiquitin, a 
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marker for protein degradation.  In normal states, there is a balance between misfolded 
proteins and destruction/repair via the ubiquitin-proteosomal system.  In PD, it is 
theorized that increased rates of misfolded α-synuclein and/or an inefficient ubiquitin-
proteosomal system are possible mechanisms for the abnormal aggregation and 
development of Lewy inclusion bodies.  Unfortunately, there is no direct evidence on 
what triggers the high rate of α-synuclein aggregation. 
 
 
 
 
 
 
 
 
 
 
 
 
It is also not known whether these Lewy structures are an adaptive or 
maladaptive cellular response or even if they are the cause of nigrostriatal cell attrition.  
Some studies have demonstrated that it is not the Lewy inclusion bodies that are the 
problem but rather it is the constituents of these inclusions (i.e., intermediate forms of 
α-synuclein) that are the culprits.  Whatever the case, all current evidence points to a 
Genetic factors 
(PARK1- PARK13) Environmental factors 
α-synuclein misfolding 
and aggregation 
Lewy bodies and neuritis 
in dopaminergic cells 
Nigrostriatal nerve cell 
death 
Figure 1.  Model of disease pathway in PD.  Adapted from Goedert (Goedert, 2001). 
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disease process that consists of a combination of genetic and environmental factors that 
triggers a cascade of events (likely via α-synuclein dysfunction and Lewy body 
formation) that ultimately results in the loss of dopamine producing nigrostriatal 
neurons. 
 
Mitochondrial dysfunction in PD 
Some studies have demonstrated that α-synuclein promotes mitochondrial 
alterations that may result in oxidative stress and subsequent cell death (Hsu et al., 
2000).  Others have shown that intermediate, oligomeric forms (i.e. misfolded) of α-
synuclein are toxic to the cells and, therefore, underlie the death of these nigrostriatal 
neurons by inhibiting complex 1 mitochondrial respiratory function (Devi et al., 2008).  
Mitochondrial dysfunction is thought to be central to the pathogenesis of PD and is 
typically complex 1 related (i.e., nicotinamide adenine dinucleotide phosphate 
(NADH):ubiquinone oxidoreductase) (Emerit et al., 2004; Mounsey & Teismann, 2010). 
Complex 1 respiratory dysfunction, in turn, increases the release of reactive 
oxygen species (ROS) (e.g., hydrogen peroxide and superoxide radicals), thereby 
increasing the oxidative stress on these cells.  Several studies have demonstrated that 
cellular oxidative stress plays a prominent role in cellular destruction in PD, likely by 
increasing cytosolic cytochrome C and subsequently initiating caspase-mediated 
apoptotic  signaling pathways (Mounsey & Teismann, 2010; Perier et al., 2007).  In 
addition, defects in complex 1 respiration lower the threshold for mitochondrial-
dependent apoptosis, a crucial event in nigrostriatal degeneration (Perier et al., 2005).   
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Increasing oxidative stress, in turn, can increase the susceptibility of α-synuclein 
to misfolding (S. Xu et al., 2006).  Thus, a vicious cycle of oxidative stress, α-synuclein 
misfolding and subsequent α-synuclein aggregation, complex 1 mitochondrial 
dysfunction, and nigrostriatal cell death is proposed (Figure 2).  This vicious cycle 
implicates any potential endogenous or exogenous complex 1 inhibitor as a potential 
contributor to the cascade of events that leads to cell death.  In addition, it suggests 
that any endogenous or exogenous agent that can reduce reactive oxygen species or 
oxidative stress may afford neuroprotection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
Neurotoxicity 
Mitochondrial apoptotic pathways 
Mitochondrial complex 1 
dysfunction 
α-synuclein 
aggregration 
Reactive oxygen 
species 
Complex 1 inhibitors: 
MPTP 
6-OHDA 
Rotenone 
 
Oxidative stress 
Endogenous antioxidants: 
Superoxide dismutase 
Catalase 
Glutathione peroxidase 
Point mutations in α-synuclein gene 
Triplication of α-synuclein gene 
Figure 2.  A vicious cycle of dopaminergic cell death in PD. 
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It is not known what initiates this proposed cycle in PD or whether mitochondrial 
dysfunction precedes α-synuclein aggregation or vice versa.  However, there is no doubt 
that they are intrinsically linked.  It is logical to consider that increased dysfunction at 
any of the steps in the vicious cycle could trigger or potentiate this cycle.  ROS like 
superoxide radicals and hydrogen peroxide are the normal byproducts of mitochondrial 
respiration and they are typically controlled by a range of antioxidants (e.g., superoxide 
dismutase, glutathione peroxidase, catalase); however, in certain pathological states, 
like PD, the amount of ROS produced swamps the antioxidant protection mechanisms.  
In addition, there is considerable evidence that neuroinflammatory processes may also 
play a role by increasing oxidative stress (E. C. Hirsch & Hunot, 2009). 
Point mutations in the gene encoding α-synuclein (i.e., PARK1) or abnormally 
high levels of α-synuclein caused by PARK4 overexpression may trigger the development 
of PD; either of these mechanisms would be sufficient to increase the rate of misfolding 
which would then presumably overwhelm the removal capacity of the ubiquitin-
proteosomal system (Figure 3).  However, only a minority of individuals with PD have 
these genetic characteristics.  In the cases of unknown cause or idiopathic PD, there are 
a few possibilities:  1. complex Mendelian inheritance has hindered genetic links (i.e., 
complex inheritance patterns would be incomplete dominance, co-dominance, 
polygenic traits); 2. undiscovered environmental triggers have remained elusive; and, 3. 
a combination of the previous two. 
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Environmental toxins have become the target of considerable research in PD 
because they are able to produce oxidative stress, a prominent factor in PD, in animal 
models of the disease (Friedrich, 2005).   Environmental toxins, like 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), and rotenone cause 
Parkinson-like symptoms in primates and rodents; these neurotoxins are also all 
 
E3 
 
Parkin 
PARK2 
 
 
 
 
  
 
 
 
 
 
UCH-L1 
(PARK5) 
 
 
Activated 
ubiquitin E1
 
U   
 
26S 
 
 
   
 
  
Conjugated ubiquitin 
E2 (UbcH7/8) 
E2 (UbcH7/8) 
Polyubiquitylated 
substrate 
Misfolded 
α-synuclein 
Inactive ubiquitin 
E4?
 
Figure 3.  Ubiquitin-proteosomal removal of misfolded α-synuclein.  Adapted from Pahwa 
(Pahwa, Lyons, & Koller, 2003). 
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complex 1 inhibitors (Mounsey & Teismann, 2010; Perier et al., 2005).  Additionally, 
rotenone can produce inclusion bodies with similar characteristics as the human Lewy 
inclusion body (Betarbet et al., 2000). Moreover, these inclusions are immunoreactive 
to α-synuclein.  Thus, these neurotoxins may enter the cycle downstream or as the 
initial precipitating factor of the disease (depending on your frame of reference) of the 
α-synuclein aggregation and may eventually cause α-synuclein aggregation by increasing 
cellular oxidative stress (Figure 2).  In support of this notion is indirect preliminary 
evidence that rotenone may cause accumulation of α-synuclein in vivo and in vitro 
(Betarbet et al., 2006). 
Theoretically, any intervention that can slow or stop any of the elements/steps 
of this proposed vicious neurodegenerative cycle in PD would logically decrease the 
cascade of events that leads to the death of these dopaminergic neurons.  Not 
surprisingly, anti-oxidant therapies, used to decrease the levels of reactive oxygen 
species, have been a PD research focus for many years (LeWitt, 2006; Mounsey & 
Teismann, 2010).  While no definitive conclusions for any such therapy have been 
reached, there has been some progress and some attractive therapies including the 
following (Mounsey & Teismann, 2010): Coenzyme Q10 (ubiquinone), creatine, SS 
peptides, green tea polyphenols, mulberry wood polyphenol (oxyresveratrol), uric acid, 
Cyperus rotundus rhizome (Cyperi rhizome), Uncaria rhynchophylla, Mito-Q10 (Ghosh et 
al., 2010).  Another promising antioxidant therapy for PD is exercise. 
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Exercise in rodent models of PD 
Recent rodent research on PD has indicated that exercise may offer robust 
neuroprotection to the dopaminergic nigrostriatal neurons after the onset of toxin-
induced PD.  In these studies, exercise not only significantly improved motor function, 
but also had a positive impact on the underlying neurochemical disorder of PD (i.e., loss 
of nigrostriatal dopamine) (Cohen et al., 2003; Howells et al., 2005; Tillerson et al., 2003; 
Tillerson et al., 2001).  Tillerson et al (2001) demonstrated that forced exercise of rats 
with PD, induced by 6-hydroxydopamine (6-OHDA), significantly improved motor 
function (Tillerson et al., 2001).  Moreover, this motor improvement was coupled with 
significant sparing of the concentration of striatal dopamine and its metabolites, 
dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA).  In addition, a 
relatively high concentration of a protein responsible for sequestering dopamine in its 
synaptic vesicles, vesicular monoamine transporter (VMAT2), was consistent with the 
high concentrations of dopamine and its metabolites.  VMAT2 levels are considered to 
be a highly reliable marker of the integrity of dopamine terminals (Kilbourn et al., 1993; 
Kilbourn et al., 1996; Miller et al., 1999a; Miller et al., 1999b).   In a similar study, 
Tillerson et al (2003) demonstrated similar findings using a forced treadmill running 
protocol on a 6-OHDA rat model and a MPTP mouse model (Tillerson et al., 2003).  
Again, treadmill exercise improved motor function and increased levels of dopamine, 
DOPAC, HVA and VMAT2.  In addition, levels of several presynaptic proteins of 
dopaminergic neurons were also improved by exercise, including dopamine transporter 
(DAT) and tyrosine hydroxylase (TH), which is the rate limiting enzyme in dopamine 
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biosynthesis.  Work by Poulton and Muir (2005) and Howells et al (2005) confirmed 
previous findings that exercise in the 6-OHDA rat model is neuroprotective (Howells et 
al., 2005; Poulton & Muir, 2005).  Collectively, these findings suggest that exercise may 
have a direct protective effect on the neurochemical pathophysiology of PD rather than 
simply ameliorating its signs and symptoms through improved musculoskeletal fitness. 
Exercise may not only be beneficial in the disease state of PD (i.e., after disease 
onset), but may also be protective to dopaminergic neurons and the development of 
PD.  Cohen et al (2003) demonstrated that exercise prior to toxin-induced PD (6-OHDA) 
in rats produced profound neuroprotection of nigrostriatal neurons (Cohen et al., 2003).  
In addition, exercised rats, in contrast to control rats, had less in the way of motor 
deficits that are characteristic of this PD model.  Thus, forced exercise prior to 6-OHDA 
lesioning resulted in a milder PD symptom profile compared to rats that were not forced 
to exercise.  Three conclusions can be drawn from these results:  1. forced exercise 
prevents the development of behavior deficits characteristic of the 6-OHDA lesion 
model;  2. forced exercise attenuates the loss of striatal dopamine; and, 3. forced 
exercise increases striatal glial-derived neurotropic factor (GDNF).  This last finding was 
important because it provided evidence that GDNF may be an underlying 
neuroprotective mechanism for dopaminergic cells from 6-OHDA insult.  This is 
consistent with evidence from other studies which have demonstrated GDNF as a 
potent protector of dopaminergic neurons (Akerud et al., 1999; Choi-Lundberg et al., 
1998; Gong et al., 1999; Hoffer et al., 1994; Jaumotte & Zigmond, 2005; Kearns & Gash, 
1995; Kramer et al., 1999; Lin et al., 1993; Schatz et al., 1999).  GDNF is thought to 
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protect neurons by acting as a neurotrophic factor in providing nourishment to neurons.  
Unfortunately, there are big gaps in how GDNF accomplishes the protection.  Moreover, 
there is no other evidence in the literature about the effect of exercise on the actual 
etiological processes of the disease (e.g., oxidative stress).  Results from the 
aforementioned studies certainly warrant further investigation into the physiologic 
processes at the cellular level. 
Enriched environments, which have a voluntary exercise component to go along 
with social interaction and learning, have also been shown to improve motor function 
and to resist MPTP insult in mice PD models.  These studies have demonstrated 
decreased loss of striatal dopamine and dopamine-related transporters (i.e., DAT and 
VMAT2) (Bezard et al., 2003; Faherty et al., 2005; Jadavji et al., 2006).  In addition, 
Faherty et al (2005) also demonstrated a concomitant upregulation of GDNF (Faherty et 
al., 2005).  Interestingly, social rats (i.e., housed with several other rats) without a 
running wheel also exhibited good improvement.  
Enriched environments (Bezard et al., 2003) and exercise (Neeper et al., 1995; 
Russo-Neustadt et al., 2000; Widenfalk et al., 1999) have also been shown to 
significantly increase another possible neuroprotective agent, brain-derived 
neurotrophic factor (BDNF).  In many other studies, neuronal growth factors, such as 
GDNF and BDNF, are capable of protecting cells against oxidative stress (Williams, 1995), 
which has been consistently documented as a potential mechanism behind protein 
misfolding and dopaminergic cell depletion in PD. 
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Forced inactivity (i.e., restricted movement) prior to or after neurotoxin-induced 
PD has resulted in an exacerbation in motor function deficits and neurochemical loss 
(Tillerson et al., 2002b).  Forced inactivity prior to a mild dose of 6-OHDA, which would 
not normally produce behavioral or neurochemical deficits, not only led to significant 
behavioral deficits but also resulted in an exacerbation of striatal dopamine, DOPAC and 
HVA loss as well as significant decreases in DAT, VMAT2, and TH.  Thus, by forcing a rat 
to be inactive (i.e., restricted movement) it causes an appearance of more severe PD 
symptoms with an associated worsening of nigrostriatal neurochemical function.  In the 
control rats (no movement restriction and same mild 6-OHDA dose) there were no 
observable PD symptoms and nigrostriatal neurochemistry was not distinguishable from 
rats that had had a sham neurotoxin.  Thus, forced inactivity turns a very mild 6-OHDA 
lesion, which produces no PD symptoms and does not affect nigrostriatal chemistry, into 
a symptom and PD profile that is consistent with a much larger lesion. 
Following severe 6-OHDA exposure and forced recovery, forced inactivity caused 
a return of motor behavior deficits and a decrease in dopamine, DOPAC, HVA, DAT, 
VMAT2, and TH (Tillerson et al., 2002b).  The implication of these findings is that 
exercise salvages these dopamine cells, but the neuroprotection is fragile and needs to 
be maintained by regular exercise.  Recently, Caudel et al (2007) demonstrated that 
decreased physical activity or movement during the process of nigrostriatal damage is 
not merely a symptom of dopamine loss but may contribute to an exacerbation in 
neurochemical and behavioral asymmetry in MPTP mice (Caudle et al., 2007).   Some 
authors have reported that an overall decrease in physical activity precedes the onset of 
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the cardinal symptoms in human PD (Comella et al., 1994; Fertl et al., 1993; Mazzoni & 
Ford, 1999; Toth et al., 1997).  This led Tillerson et al (2002) to hypothesize that 
decreased physical activity is not only a symptom of PD, but perhaps a catalyst in the 
neurodegenerative process of PD (Tillerson et al., 2002b). 
There is not a perfect animal model for PD (Ceravolo et al., 2006; Lang, 2006).  
There are some issues with the sudden onset of PD symptoms produced by neurotoxins 
in rat and mouse models.  In human PD, the neurodegenerative process is 
comparatively slow and progressive, whereas, in the toxic rodent model the 
neurodegeneration is acute and sudden (Galati & Di Giovanni, 2010; Lang, 2006).  Also, 
neurodevelopment, plasticity, life span and degeneration are also on different 
trajectories in the rodent models compared to human PD.  However, the MPTP (mouse 
and primate) and 6-OHDA (rat) models of PD are the most commonly used models of PD 
and have shed some important light on the many different putative neuroprotective 
therapies.  Translating these neuroprotective therapies into human clinical research has 
not yet proved fruitful at this time.  Therefore, clinicians and researchers should 
cautiously generalize the aforementioned animal findings on exercise to human PD.  
However, it should be remembered that rodent models of PD are of merit because they 
offer important direct data on the shared neurobiology of the nigrostriatal pathways 
that are affected in PD.  This cannot be done to the same extent in human PD.  
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Exercise in non-pathologic rodent models that relates to PD 
Exercise causes a plethora of benefits in rodent models, some of which are 
relevant to PD.  Exercise has been shown to improve performance in learning and 
memory tasks in rat models (Radak et al., 2001) and enhance brain plasticity (Cotman & 
Berchtold, 2002; Cotman & Engesser-Cesar, 2002).  If has been shown to increase serum 
calcium levels which is then transported to the brain where it stimulates dopamine 
through a calcium/calmodulin-dependent system (Sutoo & Akiyama, 2003).  Exercise is 
also associated with Hsp70 induction in the muscles of treadmill running rats (Noble et 
al., 2006). 
Exercise has been shown to increase levels of antioxidants enzymes in rodent 
muscle (Ji, 1993; Powers et al., 1993) and brain (Liu et al., 2000; Somani et al., 1995; 
Teixeira et al., 2008).  However, none of these researchers investigated the antioxidant 
levels in the substantia nigra where nigrostriatal cells degenerate in PD.  Therefore, the 
next logical step would be to determine if, in fact, the antioxidant levels would increase 
as a result of exercise in a brain region immediately relevant to the neurodegeneration 
of PD.  Linking an increase in exercise-induced antioxidants to the proposed vicious cycle 
of dopaminergic cell death in PD would be an important neurobiological finding for PD 
and other neurodegenerative diseases that have similar molecular neuropathology (i.e., 
Alzheimer’s disease).  Such a link would also provide an attractive, evidenced-based 
rationale for ameliorating the underlying disease course in PD. 
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Exercise in human PD 
At present, there is no direct evidence that exercise is neuroprotective in human 
PD.  However, there is some downstream evidence of the neuroprotective potential of 
exercise in human PD.  First, physical exercise has been shown to be beneficial in 
persons with PD (Crizzle & Newhouse, 2006; de Goede et al., 2001; Suchowersky et al., 
2006b).  This benefit is mostly in the form of motor function improvements.  In addition, 
recent epidemiologic research suggests that exercise may offer some protection against 
PD.  Based on their study of 48,574 men and 77,254 women, Chen et al (2005) reported 
that physical activity or strenuous exercise in early adult life was inversely related to PD 
risk in men (Chen et al., 2005).  Strenuous exercise was associated with a 60% lower PD 
risk in men.  It was also found that men with PD were consistently less physically active 
than men without PD up to 12 years prior to diagnosis.  However, this inverse 
relationship was not demonstrated with statistical significance (p = 0.06) in women.  
Sasco et al (1992) also reported a slight protective effect of moderate to heavy sports 
participation in adulthood on the risk for PD in a study of 50,002 men (Sasco et al., 
1992).  It has also been reported that in young onset PD “…early exposure to well water 
drinking and head trauma may trigger and expedite the appearance of PD features, but 
such acceleration may be prevented through regular exercise” (Tsai et al., 2002).  Taken 
together, these studies seem to support the data from rodent PD models of exercise in 
that exercise may offer neuroprotection to relevant pathways in PD. 
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Summary 
Parkinson’s disease is a common neurodegenerative that causes a gradual but 
profound loss of functioning in the life of those affected.  Treatment is mostly palliative 
and does little to disrupt the degenerative process.  In lieu of the elusive cure, some 
researchers have focused their attention on discovery of neuroprotective treatments 
that can affect the underlying disease course by preventing the onset of the disease or 
by slowing it down.  However, discovering neuroprotection in PD has proven difficult 
and at present there has been little success (Antonini, 2011; Biglan & Ravina, 2007; 
Galati & Di Giovanni, 2010; Hauser & Zesiewicz, 2006; Kieburtz, 2006, 2010; Lang, 2006; 
LeWitt, 2006; Poewe, 2006).  So far, no treatment has been shown to significantly slow 
the progression of the disease (Suchowersky et al., 2006a).  However, it remains an 
important goal in PD research and warrants investigation. 
In this dissertation, the overarching goal that guided the designs was to verify 
the role exercise as a viable and valid neuroprotective agent in a toxin-induced 
hemiparkinsonian rat model.  To accomplish this goal, three different aims were 
analyzed using comparative-control designs.  The first aim (Chapter 2) addressed the 
role of 4 weeks of forced exercise and no exercise in rats after a toxin-induced 
hemiparkinsonian.  The intent of this aim and subsequent design was to determine if 
exercise prevented motor asymmetry after experimental lesioning.  The second aim 
(Chapter 3) involved a 4-week preconditioning of exercise prior to induction of 
hemiparkinsonism.  The hypothesis of this aim was that exercise prior to toxin-induced 
hemiparkinsonism would prevent motor asymmetry relative to no exercise.  The third 
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aim (Chapter 4) was to compare 6 weeks of forced and voluntary exercise compared to 
a control group and a sham lesioned group.  This design was cast to determine if 
exercise was protective against behavioral motor asymmetry; however, more 
importantly, it was cast to determine if a stressful running condition (forced exercise) 
was more protective than a non-stressed running condition (voluntary exercise).  
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CHAPTER 2 
 
Forced exercise after induction of 6-OHDA-mediated nigrostriatal insult:  
neuroplasticity in an adult hemiparkinsonian rat model 
 
Abstract:  Forced exercise has been shown to ameliorate behavioral symptoms in an 
adult rat model of Parkinson’s disease (PD).  Importantly, forced exercise has been 
shown to increase dopamine and nerve growth factors; this suggests that it might affect 
the underlying disease course.  However, there are a few studies that have found mixed 
results in the rodent PD model after PD induction with neurotoxin.  Therefore, the 
purpose of this study was to explore the role of a forced exercise after toxin-induced PD 
in rats in decreasing behavioral asymmetry.  Hemiparkinsonian symptoms were induced 
using a unilateral injection of 6-OHDA in the right medial forebrain bundle.  Rats were 
then randomized into two 4-week experimental conditions, an exercise condition and a 
non-exercise control condition.  Parkinsonian behavioral tests (i.e., apomorphine 
rotations, forelimb placement asymmetry, exploratory rearing) did not show any 
significant differences over time between the two groups.  These results are not 
consistent with previous research that has found a positive treatment effect with 
exercise and cast doubt on the claims that exercise after neurotoxin induced-PD 
recovers hemiparkinsonian symptoms. 
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INTRODUCTION 
Parkinson’s disease (PD) is a progressive neurodegenerative disease due to 
attrition of dopaminergic nigrostriatal fibers.  It characteristically produces the following 
cardinal signs: bradykinesia, resting tremor, postural instability and rigidity.  Many of the 
behavioral and neurochemical alterations in PD can be modeled in rats by using a 
unilateral infusion of the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) into 
the nigrostriatal fibers.  In this rat hemiparkinsonian model, the unilateral infusion of 6-
OHDA will cause an asymmetry of movement (hemiparkinsonism) in the rat forelimb 
that can be used to determine the severity of parkinsonian symptoms.  Importantly, 6-
OHDA animals with severe destruction of the nigrostriatal system (>95%) will not display 
any behavioral recovery; however, a less severe lesion (>80%) will demonstrate some 
behavioral recovery-associated neuroadaptation (e.g., increased dopamine synthesis) in 
the remaining dopaminergic neurons (Tillerson & Miller, 2002). 
Decreased physical activity during the degenerative process has been shown to 
exacerbate behavioral and neurochemical loss in unilateral parkinsonian rats.  Tillerson 
et al (2002) found that forced-nonuse, which is akin to decreased activity, during the 
first 7 days post-lesion caused a marked increase in impairment compared to rats that 
were not restrained (Tillerson et al., 2002b).  While this is not the same as implementing 
exercise after neurotoxin-induced hemiparkinsonism, it does highlight the fact that 
there may be a dose dependent relationship to physical activity during the 
neurodegenerative process of the disease. 
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Much like animal models of cortical injury, forced exercise in the unilateral 6-
OHDA rat model has been shown to decrease the behavioral and neurochemical deficits 
associated with the disease.  Tillerson et al (2001) found that moderate exercise 
initiated soon after unilateral insult resulted in an attenuation of dopaminergic loss and 
a sparing of behavioral impairment (Tillerson et al., 2001).  The characteristic limb-use 
asymmetry was absent in rats that were forced to run, whereas those rats that were in 
the sedentary control maintained a marked limb-use asymmetry throughout the course 
of the experiment.  In another study by Tillerson et al, exercise following nigrostriatal 
damage reduced motor symptoms and increased dopamine and its metabolites in the 6-
OHDA hemiparkinsonian model (Tillerson et al., 2003).  Tajiri et al (2010) found that 
forced exercise initiated immediately after a 6-OHDA lesion was better than sedentary 
rats in terms of motor recovery; using bromodeoxyuridine (BrdU) to label proliferating 
cells, they demonstrated that exercised rats had a significant preservation of tyrosine 
hydroxylase positive cells in the striatum and substantia nigra (Tajiri et al., 2010).  
Exercise has also driven similar findings in the MPTP (1-Methyl-4-Phenyl-1,2,3,6-
Tetrahydropyridine) mice model of PD (Fisher et al., 2004). 
While previous studies have shown improvements in the motor recovery of the 
Parkinsonian rat by forcing them to exercise, a more important finding was that the 
exercise improved the levels of dopamine in relevant brain areas.  This suggests that 
forced exercise may actually affect the underlying disease course by preserving 
dopaminergic neurons.  While this provides some indirect information that exercise may 
mitigate the damage to dopaminergic neurons, there is no direct evidence to explain 
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why these dopaminergic neurons are preserved and, importantly, what influence forced 
exercise has on the underlying molecular causes of dopaminergic cell loss (i.e., 
apoptosis).  Therefore, the primary purpose of this study was to explore the role of 
forced exercise after 6-OHDA-induced nigrostriatal dysfunction in a hemiparkinsonian 
rat model. 
 
METHODS 
Overall study design 
Twenty-six male Long Evans rats (Charles River Laboratories, Hollister, California, 
USA) aged 91-100 days were used for this experiment.  All handling and procedures 
were in accord with NIH Guide for the Care and Use of Laboratory Animals and 
approved by the University of Nevada, Las Vegas Institutional Animal Care and Use 
Committee.  The rats first received a unilateral Parkinsonian lesion as described below 
and then were randomly assigned into one of two 4-week treatment conditions: 
exercise and non-exercise control (Figure 4).  These rats, housed individually and fed ad 
libitum, weighed between 360 and 457 grams (mean=400.4 grams, SD=24.8) at the time 
of randomization.  Rats were tested for PD severity using behavioral tests prior to and 
after the treatment conditions.  Three different behavioral tests were used to create a 
comprehensive assessment of the PD severity (Metz & Whishaw, 2002).  
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Surgical procedures 
After a one-week acclimatization period, animals were anesthetized using an 
intraperotoneal injection of 75 mg/kg Ketamine and 0.25 mg/kg dexmedetomidine.  In 
order to block noradrenergic uptake sites and thereby prevent noradrenergic toxicity, 
15 mg/kg desipramine hydrochloride dissolved in saline was injected intraperotoneally 
30 minutes before the neurotoxin was injected (Anstrom et al., 2007; O'Dell et al., 
2007).  The rats were then placed in a stereotactic frame (Kopf 900, David Kopf 
Instruments, Tujunga, California, USA). 
 
  
26 male, Long 
Evans Rats 
360-457 grams 
 
Motor behavior tests:  
• Apomorphine rotations 
• Forelimb placing asymmetry 
• Exploratory rearing 
 
1 week acclimatization 
Unilateral 6-OHDA lesion 
(3 rats died during surgery) 
1 week period to allow Parkinsonian symptoms to develop 
11 rats: Control condition  
4 weeks 
 
12 rats: Exercise condition 
4 weeks 
 
Random assignment 
Figure 4.  Overall study design. 
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The scalp was shaved, swabbed with povidone-iodine topical antiseptic and a 
central incision was made to expose the skull and bregma.  A 1 mm burr hole was then 
drilled through the cranium to gain exposure to the cranial cavity at the following 
stereotactic coordinates: 3.3 mm posterior to bregma, 1.9 mm lateral, 8.2 mm ventral to 
skull surface (Paxinos & Watson, 1998; Paxinos et al., 1985; Tillerson et al., 2003; 
Tillerson et al., 2002b).  A unilateral Parkinsonian lesion was induced with 10 μg of 6-
hydroxydopamine hydrobromide in 0.1% ascorbic acid (6-OHDA; Sigma, St. Louis, USA) 
or 2,4,5-trihydroxyphenethylamine in 4 μl of 0.9% saline injected into the right 
nigrostriatal fibers that make their way to the striatum via the medial forebrain bundle 
(Mabandla et al., 2004; Moroz et al., 2004; Tillerson et al., 2003; Tillerson et al., 2002b; 
Tillerson et al., 2001).  This infusion would equate to roughly an 80% loss of 
dopaminergic cells (Tillerson et al., 2003).  A 28-guage 5 μl-microliter syringe (Hamilton, 
Reno, Nevada) was used to slowly inject the 6-OHDA at a rate of 1 μl/min for 4 minutes 
into the right medial forebrain bundle. 
Following injection of the neurotoxin, the burr hole was closed using bone wax 
and standard suturing techniques were used to close the incision.  During the surgery 
and recovery, rats were kept warm using a warm heating pad and heating lamp.  Rats 
were brought out of surgical analgesia using 1ml/kg atipamezole (subcutaneous 
injection into the flank).  Rats received postoperative analgesia daily for three days using 
a 0.01mg/kg subcutaneous injection of buprenorphine into the flank.  During surgery, 
three rats died.  Therefore, the remaining 23 rats were randomized into the two 
experimental conditions. 
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Parkinsonian behavioral testing 
After a one week post-surgical recovery period, the rats were tested to 
determine their motor behavioral severity of PD prior to entry into the experimental 
conditions.  After the 4-week experimental period, the rats were tested again with the 
same tests of PD motor severity.  This was done using apomorphine-induced rotations, 
forelimb placement asymmetry, and exploratory rearing.   
Due to neurotoxin-induced denervation, the dopamine receptors on the affected 
side (i.e., injected side) become hypersensitive in the hemiparkinsonian rat.  
Apomorphine, a dopamine agonist, stimulates these receptors causing an asymmetrical 
increase in striatal activity on that side relative to the non-affected side.  This causes a 
rapid, repetitive turning of the body away or contralateral from the lesioned side (Da 
Cunha et al., 2008).  The number of complete 360° turns within 30 minutes in a round 
bowl has been shown to correlate well with lesion severity in terms of dopaminergic cell 
loss (Hudson et al., 1993; Metz & Whishaw, 2002).  Thus, it was felt that apomorphine-
induced rotations would be a good indicator of the severity of the hemiparkinsonian 
lesion.  Animals were injected with 0.5mg/kg apomorphine hydrochloride (Sigma, St. 
Louis, USA) dissolved in saline subcutaneously and then immediately videotaped from 
above (Joghataie et al., 2004; Mabandla et al., 2004; Roghani & Behzadi, 2001; Tillerson 
et al., 2002b).  The number of times the animal rotated 360° in each direction over a 30-
minute period was counted using the videotape at a later time.  The number of 
ipsilateral rotations subtracted from the number of contralateral rotations resulted in a 
net number of contralateral rotations (Poulton & Muir, 2005). 
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Forelimb placement asymmetry while rearing in a cylinder was evaluated using 
similar protocols established in previous studies  (Moroz et al., 2004; O'Dell et al., 2007; 
Poulton & Muir, 2005; Schallert & Tillerson, 1999; Tillerson et al., 2003; Tillerson et al., 
2002b).  Each rat was placed in a 22 cm diameter by 26 cm high cylinder for 10 minutes 
and videotaped from above.  As the rats explored the walls of the cylinder during 
rearing, they used one or both forelimbs to contact the wall for support during 
exploration.  Independent use of the impaired, which would be the left forelimb since 
the contralateral nigrostriatal fibers were lesioned, and unimpaired (right forelimb) 
forelimbs were counted for each rearing episode.  These values were then scored using 
the following asymmetry ratio:  (Right - Left)/(Right + Left + Both)(O'Dell et al., 2007).  
Scores on the asymmetry ratio range from -1 to 1 with a high positive ratio being 
suggestive of a greater use of the unimpaired forelimb over the impaired forelimb.  A 
negative asymmetry ratio would be indicative of greater use of the impaired forelimb 
relative to the unimpaired forelimb.  Thus, a high positive asymmetry ratio would be 
consistent with a hemiparkinsonian lesion. 
The number of times that a rat reared during a 10 minute videotaped period was 
referred to as exploratory rearing.  While this has not been documented previously in 
the literature, it was felt that exploratory rearing would be a potential new behavioral 
test for hypokinesia which is a common symptom of PD. 
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Exercise protocol 
Immediately after behavioral testing, the 23 rats were randomly assigned into 
one of two 4-week experimental conditions: exercise and control.  The control condition 
consisted of 11 rats that were housed individually with no exercise equipment and were 
not exposed to any exercise for 4 weeks.  The exercise condition consisted of 12 rats, 
one of which became ill and died (cause unknown per veterinarian) during the 4-week 
forced exercise regimen.  This exercise condition consisted of forced exercise using a rat 
treadmill (Exer 3/6 Treadmill from Columbus Instruments, Columbus, Ohio, USA) five 
days per week for 4 weeks during the light cycle.  The rats received 2 bouts of 15 minute 
running periods (separated by at least 1 hour) per day at a speed of 15 meters per 
minute (Tillerson et al., 2003).  The Exer 3/6 Treadmill is equipped with an electrical grid 
on the posterior portion of the treadmill.  If the rats’ tail or hind limb made contact with 
the grid, an electrical stimulus strong enough to elicit an aversive reaction would serve 
as a negative reinforcer for running noncompliance.  The electrical stimulus was set at 
200 millisecond pulses with an adjustable pulse repetition rate of 1 to 4 per second. The 
intensity was adjustable from 0.35 mA to 3.4 mA and depended on the responsiveness 
of the particular rat to the stimulus. 
 
RESULTS 
Apomorphine rotations.  A 2 (time: pre and post) X 2 (condition: exercise and non-
exercise control) mixed factorial ANOVA was conducted to determine if there was an 
interaction between time and condition on apomorphine rotations.  There was no 
31 
 
interaction between the variables for apomorphine rotations, P = 0.121 (power = 0.338; 
Table 2, Figure 5).  There was, however, a significant main effect for time (P < 0.001; 
Table 3) suggesting that, regardless of experimental condition, there was an increase in 
apomorphine rotations from the pre (mean=188.4, SD=71.4) to the post (mean=284.6, 
SD=71.5).  There was no main effect for condition (p=.906; Table 4). 
 
Table 2.  Descriptive statistics of apomorphine rotations. 
 Condition Mean 
Std. 
Deviation 
N 
Pre 
Runners 179.6 53.1 11 
Non-runners 197.2 87.8 11 
Post 
Runner 296.8 73.7 11 
Non-runners 272.5 70.5 11 
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Figure 5.  Interaction of time and condition on apomorphine rotations. 
 
Figure 5.  Means and standard deviations for the number of apomorphine-induced 
contralateral rotations during a 30-minute testing period for runners and non-runners 
before and after 4 weeks of experimental treatment. 
 
Table 3.  Main effect for time on apomorphine rotations. 
Time Mean 
Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Pre 188.4 15.5 156.1 220.6 
Post 284.6 15.4 252.6 316.7 
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Table 4.  Main effect for condition on apomorphine rotations. 
Condition Mean 
Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Runners 238.2 19.8 196.9 279.5 
Non-runners 234.8 19.8 193.5 276.1 
 
 
 
Forelimb placement asymmetry.  A 2 (time: pre and post) X 2 (condition: exercise and 
non-exercise control) mixed factorial ANOVA was conducted to determine if there was 
an interaction between time and condition on forelimb placements.  There was no 
interaction for forelimb placement asymmetry, P = 0.497 (power = 0.101; Table 5, Figure 
6).  There was a main effect for time (P < 0.001; Table 6) which suggests that all of the 
animals had significant asymmetry at the pre measurement (72.9% unimpaired over 
impaired forelimb use) which decreased significantly at the post measurement (38.4% 
unimpaired over impaired forelimb use).  There was not a significant main effect for 
experimental condition (P = 0.341, power = 0.153; Table 7). 
 
Table 5.  Descriptive statistics for forelimb placement asymmetry. 
 Condition Mean 
Std. 
Deviation 
N 
Pre 
Runners .758 .304 11 
Non-runners .700 .272 11 
Post 
Runners .460 .334 11 
Non-runners .309 .273 11 
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Figure 6.  Interaction of time and condition on forelimb placement asymmetry. 
 
Figure 6.  Means and standard deviations of the forelimb placement asymmetry ratio 
during a 10-minute testing period for runners and non-runners before and after 4 weeks 
of experimental treatment. 
 
Table 6.  Main effect of time for forelimb placement asymmetry. 
Time Mean 
Std. 
Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Pre .729 .062 .601 .858 
Post .384 .065 .249 .520 
 
 
Table 7.  Main effect of group for forelimb placement asymmetry. 
Condition Mean 
Std. 
Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Runners .609 .076 .451 .767 
Non-runners .504 .076 .346 .663 
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Exploratory rearing.  A 2 (time: pre and post) X 2 (condition: exercise and non-exercise 
control) mixed factorial ANOVA was also used to determine if there was an interaction 
for exploratory rearing.  There was not a statistically significant interaction between 
time and condition, P = 0.315 (power = 0.166; Table 8, Figure 7).  There was not a main 
effect on condition, P = 0.260 (power = 0.166; Table 9); however, there was a main 
effect on time (P < 0.001; Table 10) with less exploratory rears at the pre measurement 
(mean = 6.6, SD = 0.9) compared to the post measurement (mean = 14.5, SD = 1.3). 
 
Table 8.  Descriptive statistics for the number of exploratory rears. 
 Condition Mean 
Std. 
Deviation 
N 
Pre Runners 7.0 4.1 11 
Non-runners 6.2 4.3 11 
Post Runners 16.3 6.1 11 
Non-runners 12.8 6.3 11 
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Figure 7.  Interaction between time and condition on exploratory rearing. 
 
Figure 7.  Means and standard deviations of the number of exploratory rearing episodes 
during a 10-minute testing period for runners and non-runners before and after 4 weeks 
of treatment. 
Table 9.  Main effect of condition on exploratory rearing. 
Condition Mean 
Std. 
Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Runners 11.6 1.3 8.9 14.4 
Non-runners 9.5 1.3 6.8 12.2 
 
 
Table 10.  Main effect of time on exploratory rearing. 
time Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Pre 6.6 0.9 4.7 8.5 
Post 14.5 1.3 11.8 17.3 
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DISCUSSION 
Results of this study do not support the notion that exercise after neurotoxin-
induced hemiparkinsonism is beneficial.  In general, treadmill trained animals did not 
improve more than sedentary non-runners in any of the three behavioral tests.  Of these 
tests, all of the rats regardless of group, runner and non-runner, improved in two of the 
outcome tests (i.e., forelimb placement asymmetry, exploratory rearing) and got worse 
in one (i.e., apomorphine rotations).  The results of this study are not consistent with 
the literature and cast doubt on previous assertions of the robustness of the 
neuroprotective treatment effect of exercise in an adult 6-OHDA rat model of PD. 
A majority of previous research suggests that exercise ameliorates motor deficits 
in the 6-OHDA model of PD (Howells et al., 2005; Mabandla et al., 2004; Moroz et al., 
2004; O'Dell et al., 2007; Smith & Zigmond, 2003; Tajiri et al., 2010; Tillerson et al., 2003; 
Tillerson et al., 2001; Vergara-Aragon et al., 2003) and also in other rodent models of PD 
(Caudle et al., 2007; Fisher et al., 2004).  These studies served as the theoretical 
foundation for the present study.  While there were some differences in the modality of 
the exercise regimen, the overall study designs were fairly consistent.  The dosing of the 
exercise in the present study was consistent with several of the studies (Poulton & Muir, 
2005; Tajiri et al., 2010; Tillerson et al., 2003); however, the dosing in the present study 
was more intense than the Moroz et al study (2 weeks of 15-30 minutes of running in 
plastic balls) and the Mabandla et al study (2 weeks of exercise in free running wheels 
(average of 4361 revolutions per day)) (Mabandla et al., 2004; Moroz et al., 2004).   Only 
the O’Dell et al (2007) study had a more intense exercise protocol (4 weeks of voluntary 
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running wheel for >1000 meters/day plus 10.5 meters per minute for 30 minutes of 
forced running) (O'Dell et al., 2007).  Since the exercise dosing for the present study was 
consistent with the previous studies that showed a treatment effect with exercise, it is 
not likely that the lack of treatment effect in the present study had anything to do with 
the dosing of the treadmill exercise. 
While the results of this study were not consistent with the body of the literature 
on rodent exercise and PD, there was another study that likewise did not find an 
exercise treatment effect.  Poulton and Muir (2005) found that treadmill training did not 
affect behavioral deficits in the 6-OHDA Parkinsonian rat model (Poulton & Muir, 2005).  
This study had an exercise protocol (4 weeks of 40 minutes/day at 13 meters/minute) 
that was similar in duration and intensity.  Taken together, the results of the present 
study and those of Poulton and Muir (2005) study cast doubt on the positive treatment 
effect of exercise reported after 6-OHDA injection.  In light of this lack of consensus in 
the literature, further research is warranted. 
The reason for the worsening (i.e., increase in the number of contralateral 
rotations) in the apomorphine rotations over time in both of the groups is likely a 
function of the time it takes for the neurotoxin to cause oxidative damage and eventual 
apoptosis (Cerruti et al., 1993; Crocker et al., 2001; Decker et al., 1993; Glinka et al., 
1997; Hudson et al., 1993).  Generally, it is thought that it takes 1-2 weeks in the 6-
OHDA model.  However, some researchers suggest that the neurotoxic effects of 6-
OHDA continue to cause apoptosis well past 2 weeks and even up to 28 days after the 
injection (Bjorklund et al., 1997).  In the present study, the pre measurement was taken 
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approximately 1 week after the 6-OHDA lesion; this would have been at the early end of 
the range of dopaminergic toxicity.  The post measurement was taken approximately 
five weeks after the 6-OHDA injection; presumably, the full effect of the neurotoxin 
would have been realized by that point.  Thus, it is logical that the apomorphine 
rotations had increased over the duration of the study because the toxicity of 6-OHDA 
on the dopaminergic neurons was protracted. 
One of the most logical reasons for a lack of treatment effect was the delay in 
treadmill treatment following the 6-OHDA lesioning.  In the present study, the animals 
started the exercise regimen 7 days after the lesioning.  Tillerson et al (2001) reported 
that exercise started early in the first week after surgery, but not after the first week, 
prevented the preferential use of the unimpaired forelimb and reduced contralateral 
apomorphine rotations (Tillerson et al., 2001).  Indeed, in the studies where a positive 
exercise treatment effect was observed, the start for exercise after 6-OHDA lesioning 
was very soon after the injection of the neurotoxin: 2-4 hours post-lesioning (Tillerson et 
al., 2003), and 4-5 hours post-lesioning (Moroz et al., 2004), and 24 hours (Howells et 
al., 2005; Mabandla et al., 2004; O'Dell et al., 2007; Tajiri et al., 2010).  While it appears 
that early intervention is an important component of neuroprotection, it should be 
noted that early exercise may have increased blood flow in behaviorally relevant brain 
locations (i.e., nigrostriatal pathways) and this may have actually flushed neurotoxin 
from that brain region.  Thus, the neuroprotective effect of exercise may not have been 
mediated by an effect on the underlying disease course.  However, this is purely 
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speculative but could, if true, represent a threat to the validity of exercise as a 
neuroprotective agent in neurotoxin-induced PD. 
Only one study with a positive exercise treatment effect reported an exercise 
start time beyond the one week window (i.e., 21 days post lesion)(Vergara-Aragon et al., 
2003). However, it should be noted that in the Poulton and Muir (2005) study, where no 
exercise treatment effect was observed, the start time for the early group was 24 hours 
after surgery and the late group was 1 week after surgery (Poulton & Muir, 2005).  
While there is not complete consensus, taken together, it appears that exercise should 
begin soon after 6-OHDA lesioning because it may interfere with the slowly developing 
dopaminergic toxicity (i.e., 1-2 weeks).  It is possible that an early window of 
opportunity may have been missed because of the delayed start in the implementation 
of the forced exercise.  This represents a limitation in the design of the present study. 
Another logical reason for the lack of a positive exercise treatment effect is that 
exercise protocol-related stress may have negated the beneficial effects of exercise.  
Howells et al found that exercise does improve hemiparkinsonian behavioral symptoms; 
however, mild stressors may cancel the neuroprotection afforded by the voluntary 
exercise (Howells et al., 2005).  Moroz et al (2004) also reported that repeated saline 
injections (a form of stress) to rats with free access to running wheels cancelled the 
beneficial effects of exercise (Moroz et al., 2004).  In the present study, a “forced” 
exercise protocol was utilized wherein animals were forced to run using negative 
reinforcement.  Rats in the exercise group ran on a treadmill equipped with an electrical 
grid on the posterior portion.  Noncompliance with the running would cause the tail or 
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hind limb/s to make contact with an electrical grid causing a stimulus strong enough to 
elicit an aversive reaction.  While this aversive stimulus served as a negative reinforcer 
for running noncompliance, it may have created a stressful environment for the animal 
thereby potentially negating the positive treatment effect of exercise.  Subsequently, 
the possibility that stress may have negatively affected the neuroprotective effect of 
exercise cannot be ruled out.  A future study using an exercise modality without an 
aversive stimulus or reinforcer would be necessary to clear up this issue.  In addition, a 
brief preconditioning trial of the treadmill exercise prior to the surgery may have 
familiarized the animals with the treadmill and the associated aversive stimulus; this 
may have decreased the stress experienced during the first few days of treadmill use 
post injection when the rats were being conditioned to run. 
 
CONCLUSIONS 
The results of the present study demonstrated that treadmill training in a 6-
OHDA model of PD did not mitigate the behavioral deficits of hemiparkinsonism.  This 
study casts doubt on the previously held assertion that exercise ameliorates behavioral 
deficits in rodent models of PD.  These results are in contrast to several studies that had 
found a robust treatment effect of exercise after induction of the disease; however, the 
present findings are consistent with at least one other study.  Discrepancies in the 
results of the present study and those with a positive treatment effects may by 
accounted for by differences in the type of training and assessment.  It is also possible 
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that stress-inducing electrical shocks for running noncompliance during treadmill 
training may have negated the benefit afforded by exercise.   
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CHAPTER 3 
 
Forced exercise before induction of 6-OHDA-mediated nigrostriatal insult: 
neuroprotection in an adult hemiparkinsonian rat model 
Abstract:  Recent research has shown that rats preconditioned with exercise are less 
susceptible to toxin-induced PD in terms of Parkinsonian behavioral symptoms and 
underlying levels of dopamine and its metabolites.  While these promising findings 
suggest that exercise might protect against dopaminergic attrition, there have been few 
studies that have utilized a forced exercise regimen prior to the induction of 6-
hydroxydopamine (6-OHDA) hemiparkinsonism in rats.  Therefore, the purpose of this 
study was to explore the role of forced exercise before the induction of PD with the 
intent of supporting these previous findings.  Prior to the neurotoxin-induced PD, 
animals were randomized into two 4-week experimental groups, an exercise group and 
a non-exercise control group.  After participation in the experimental conditions, 
hemiparkinsonism was induced using a unilateral injection of 6-hydroxydopamine.    
Parkinsonian behavioral tests (i.e., apomorphine rotations, forelimb placement 
asymmetry, exploratory rearing) did not show any significant differences between the 
two groups.  These results are in contrast to the literature and suggest that the notion 
that exercise is neuroprotective may be premature.  Further research is warranted. 
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INTRODUCTION 
Exercise early in life may be protective against the development of Parkinson’s 
disease (PD).  Chen et al, in a study of 125,828 men and women, found that greater 
baseline physical activity was associated with a lower risk of PD and that strenuous 
exercise in early adult life was inversely related to PD in men (Chen et al., 2005).  
Strenuous exercise resulted in a 60% lower PD risk in men.  In another very large 
epidemiologic study (i.e., 50,002 men who attended Harvard University or Penn 
University), Sasco et al (1992) found that moderate or heavy sports participation in 
college was associated with a reduced risk of PD suggesting a slight neuroprotective 
effect (Sasco et al., 1992).  In a case control study by Tsai et al (2002), they found that 
early exposure to well water drinking and head trauma may trigger and expedite the 
appearance of PD features, but such acceleration may be prevented through regular 
exercise (Tsai et al., 2002).  Taken together, these studies offer indirect evidence that 
exercise may somehow afford protection to the brain in areas relevant to PD. 
In rodent models of PD, exercise or physical activity has also been shown to be 
neuroprotective prior to the induction of PD.  Cohen et al (2003) found that forced use 
prior to experimentally induced hemiparkinsonism with 6-hydroxydopamine (6-OHDA) 
in rats prevented the development of Parkinsonian motor deficits and lessened the loss 
of striatal dopamine (Cohen et al., 2003).  Adult mice preconditioned with exercise (i.e., 
free access to a running wheel) were found to exhibit outcomes consistent with 
neuroprotection of the nigrostriatal system (i.e., dopamine transporters) against MPTP-
induced Parkinsonism (Faherty et al., 2005).  In addition, rats forced to be inactive (i.e., 
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no exercise) prior to a mild dose of 6-OHDA, which would not typically result in 
behavioral asymmetries, actually caused profound, long-term behavioral asymmetry 
and an exacerbation of the dopaminergic loss from an anticipated 20% loss to 60% loss 
(Tillerson et al., 2002b).  In essence, this study suggests the existence of a dose 
dependent relationship of physical activity and disease severity prior to PD induction.  
That is, exercise protects against the disease, whereas, inactivity makes one more 
susceptible or vulnerable.  Anstrom et al (2007) demonstrated that repetitive vibrissae-
elicited forelimb placing, which is a sensorimotor exercise modality that is similar to a 
forced exercise protocol, before 6-OHDA injection also provided a therapeutic 
behavioral benefit to animals in terms of behavioral performance and sparing of 
substantia nigra tyrosine hydroxylase immunoreactivity (Anstrom et al., 2007).  Metz et 
al (2004) also found a positive neuroprotective effect to the motor cortex due to a 
preconditioning of a skilled reaching task prior to unilateral 6-OHDA-injection (Metz et 
al., 2004).  Taken together, these studies suggest, much like the human epidemiologic 
studies, that exercise or physical activity prior to neurotoxic 6-OHDA insult may provide 
neuroprotective benefit in terms of behavioral performance and underlying disease 
processes. 
Promising results from the human epidemiologic and rodent PD neuroprotection 
studies warrant further investigation to determine if preconditioning of exercise can 
protect the PD brain in terms of motor behavior.  Several research groups have found 
exercise to be neuroprotective in other rodent disease models, like stroke and ischemia 
(Ang et al., 2003; Cechetti et al., 2008; Ding et al., 2004; Liebelt et al., 2010).  The 
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purpose, therefore, was to explore the role of forced exercise prior to the onset of 6-
OHDA hemiparkinsonism in adult rats.  Parkinsonian behavioral tests were conducted to 
determine if forced exercise mitigated behavioral deficits. 
 
METHODS 
Overall study design 
Twenty-six male Long Evans rats (Charles River Laboratories, California, USA) 
were used in this study.  These rats were housed individually under standard laboratory 
conditions with a 12 hour light/dark cycle and were fed ad libitum throughout the 
duration of the study.  The planning and execution of the experiments in this study were 
approved by the University of Nevada, Las Vegas Institutional Animal Care and Use 
Committee and were consistent with the National Institute of Health Guide for the Care 
and Use of Laboratory Animals.  All rats were initially randomized into one of two 4-
week treatment groups: forced exercise and non-exercise control (Table 11; Figure 8).    
Immediately after completely the 4-week treatment protocol, hemiparkinsonism was 
induced using an injection of the dopaminergic neurotoxin, 6-hyrdroxydopamine 
hydrochloride (6-OHDA).  Approximately 6-8 days after the neurotoxin injection, rats 
were tested for motor asymmetry using three behavioral tests: apomorphine rotations, 
forelimb placement asymmetry, and exploratory rearing.   
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Table 11.  Weight of rats at initial randomization and at 6-OHDA-induced 
hemiparkinsonism. 
 Run status N Mean Std. Deviation 
Std. 
Error  
P 
value 
Weight at 
randomization 
Runner 12 392.1 30.8 8.9 
.057 
Non-runner 8 420.9 31.5 11.1 
Weight at 
6-OHDA injection 
Runner 13 436.0 38.6 10.7 
.015 
Non-runner 10 471.6 19.3 6.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercise protocol 
After a brief acclimatization period, all 26 rats were randomly assigned into one 
of two 4-week experimental groups, a forced exercise group and a non-exercise control 
1 week period to allow parkinsonian symptoms to develop 
6-OHDA injection 
(3 died during surgery, I 
EG rat and 2 CG rats) 
 Behavioral tests: 
• Apomorphine rotations 
• Forelimb placement asymmetry 
• Exploratory rearing 
1 week acclimatization 
Random assignment 
13 rats: Exercise group (EG) 
4 weeks of exercise 
 
13 rats: Control group (CG) 
4 weeks of no exercise 
 
26 male 
Long Evans rats 
 
Figure 8. Basic overall study design. 
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group.  The non-exercise control group consisted of individually-housed rats with no 
exercise equipment or access to exercise during the 4-week experimental period.  The 
forced exercise group consisted of forced running on a 3-lane rat running treadmill 
during the light cycle (Exer 3/6 Treadmill from Columbus Instruments, Columbus, Ohio, 
USA) for five days per week.  Rats were run twice per day at a speed of 15 meters per 
minute separated by at least one hour; each running bout lasted 15 minutes for a total 
of 30 minutes per day (Tillerson et al., 2003).  An electrical grid at the back end of the 
treadmill served as an aversive stimulus if the rats came into contact with it due to poor 
running or noncompliance with the exercise.  The electrical grid had adjustable intensity 
settings (i.e., 0.35 mA to 3.4 mA) at 200 millisecond pulses with an adjustable pulse 
repetition rate of 1 to 4 per second.  This was initially set high and then once the 
running behavior was reasonably conditioned it was turned down. 
 
Surgical procedures 
After the 4-week experimental period, rats were anesthetized using an 
intraperotoneal injection of 75 mg/kg Ketamine and 0.25mg/kg dexmedetomidine.  
Desipramine hydrochloride (15 mg/kg) dissolved in saline was then injected 
intraperotoneally to preserve noradrenergic neurons 30 minutes before injection of 6-
OHDA (Anstrom et al., 2007; O'Dell et al., 2007).  This was done to mitigate attrition of 
noradrenergic neurons as 6-OHDA may also be toxic to this class of cells. 
Once the rats had achieved surgical anesthesia (i.e., deep and slow breathing, 
unresponsive to paw-pinch), they were shaved and then immediately moved to the 
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stereotactic frame (Kopf 900, David Kopf Instruments, Tujunga, California, USA) and 
placed on the incisor bar.  The head was then firmly positioned within the stereotactic 
frame by means of ear bars which were placed in the ear canals.  An eye ointment 
(GenTeal 0.3% eye gel, USA) was then coated over the eyes.  The cranium was then 
swabbed with povidone-iodine topical antiseptic.  A central incision was then made to 
expose the skull and bregma after which a 1 mm burr hole was drilled through the 
cranium to gain exposure to the cranial cavity at the following stereotactic coordinates: 
3.3 mm posterior to bregma, 1.9 mm lateral, 8.2 mm ventral to skull surface (Paxinos & 
Watson, 1998; Paxinos et al., 1985; Tillerson et al., 2003; Tillerson et al., 2002b).  These 
coordinates were used to guide the syringe into the right medial forebrain bundle which 
contains dopaminergic neurons destined for the striatum.  A 28-guage, 5 μl-microliter 
syringe (Hamilton, Reno, Nevada, USA) was then used to deliver the neurotoxin to the 
medial forebrain bundle.  A total dose of 10 μg of 6-hydroxydopamine hydrobromide in 
0.1% ascorbic acid (Sigma, St. Louis, USA) in 4 μl of 0.9% saline was injected at a rate of 1 
μl/min for 4 minutes (Mabandla et al., 2004; Moroz et al., 2004; Tillerson et al., 2003; 
Tillerson et al., 2002b).  After the four minute injection period, the syringe was carefully 
removed from the burr hole.  Following closure of the burr hole using bone wax, the 
incision was closed with 5-6 sutures using standard simple interrupted pattern suturing 
techniques.   
Rats were kept warm using a warm heating pad and heating lamp throughout 
the surgery and recovery.  Atipamezole at 1 ml/kg (subcutaneous) was used as a 
reversal agent for dexmedetomidine to bring the rats out of anesthesia.  The rats were 
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injected with this drug immediately after removal from the stereotactic frame.  The 
sutured incision was swabbed again with povidone-iodine topical antiseptic to prevent 
infection.  The entire surgical procedure did not exceed 50 minutes.  The rats were 
observed in recovery for at least one hour.  Once they became ambulatory on all four 
limbs, they received postoperative analgesia using a 0.01mg/kg subcutaneous injection 
of buprenorphine into the flank and were returned to their plastic housing units.  They 
received this same postoperative analgesia for the next three days.  Three of the 
twenty-six rats died after injection of the anesthesia medications 
(ketamine/dexmedetomidine) and prior to injection of the neurotoxin 6-OHDA.  The 
reason for these deaths was not known but according to an on-site veterinarian it was 
thought to be anesthesia related.  There were no infections noted for the duration of 
the study. 
 
Parkinsonian behavioral testing 
Approximately one week (6-8 days) after neurotoxin injection, rats were tested 
to determine motor asymmetry as a result of the injection.  The following three 
behavioral tests were used to create a comprehensive assessment: apomorphine-
induced rotations, forelimb placement asymmetry, and exploratory rearing.   
Apomorphine rotations were evaluated by injecting 0.5 mg/kg apomorphine 
hydrochloride subcutaneously in the dorsal right quadrant proximal to the pelvis (Sigma, 
St. Louis, USA) dissolved in saline subcutaneously (Joghataie et al., 2004; Mabandla et 
al., 2004; Roghani & Behzadi, 2001; Tillerson et al., 2002b).  The number of times the 
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animal rotated 360° in each direction over a 30-minute period was counted at a later 
time using a videotaped recording taken from above the animal.  Ipsilateral rotations 
subtracted from the number of contralateral rotations resulted in a net number of 
contralateral rotations (Poulton & Muir, 2005).  Complete 360° rotations within 30 
minutes in a round bowl have been shown to correlate with PD lesion severity (Hudson 
et al., 1993; Metz & Whishaw, 2002).  Thus, it was felt that apomorphine-induced 
rotations would be a good indicator of dopaminergic cell loss. 
Forelimb placement asymmetry  was evaluated first by placing the animals in a 
cylinder (22 cm wide by 26 cm high) and then initial forelimb touches to the walls of the 
cylinder (i.e., impaired left forelimb first, unimpaired right forelimb first, simultaneous) 
for each individual rearing episode were recorded (Moroz et al., 2004; O'Dell et al., 
2007; Poulton & Muir, 2005; Schallert & Tillerson, 1999; Tillerson et al., 2003; Tillerson 
et al., 2002b).  Rats were videotaped for 10 minutes from above and were then scored 
using the following asymmetry ratio:  (Right - Left)/(Right + Left + Both)(O'Dell et al., 
2007).  Scores on the forelimb asymmetry ratio range from -1 to 1 with a high positive 
ratio being consistent with greater use of the unimpaired forelimb over the impaired 
forelimb.  A negative asymmetry ratio would suggest greater use of the impaired 
forelimb relative to the unimpaired forelimb.  Thus, a high positive forelimb placement 
asymmetry ratio would be consistent with a hemiparkinsonian lesion. 
Exploratory rearing was evaluated by observing the 10 minute video tape of the 
forelimb placement asymmetry test.  The number of times that a rat reared on it hind 
limbs during that 10 minute period was referred to as exploratory rearing.  This has not 
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been documented previously in the literature; however, it was felt that exploratory 
rearing could be a potential new behavioral test for a common symptom in PD, a paucity 
of movement (i.e., hypokinesia). 
 
Data analysis 
All analyses were conducted using SPSS version 19.0 (IBM SPSS, Chicago, Illinois, 
USA).  In order to determine if there was a difference between the forced exercise 
group and the non-exercise control group, an independent samples t-test was 
conducted for apomorphine rotations.  Apomorphine rotations were only conducted 
after the 6-OHDA injections.  As forelimb placements and exploratory rearing were 
measured at the start of the study (prior to the 4 week training period) and after at the 
end of the study (after the 6-OHDA injections), two 2 (time: pre and post) by 2 (group: 
runner and non-runner) mixed factorial ANOVAs were done, one for forelimb placement 
asymmetry and one for exploratory rearing.  In an exploratory secondary analysis, point 
biserial correlations were analyzed for the immediate post-surgical observation (i.e., 
within 20 minutes) of right neck turning (yes or no) to the three other behavioral tests in 
the study (Figure 9).  This has not been previously documented in the literature.  It was 
felt that this immediate neck turning might correlate to the severity of the asymmetry 
caused by the 6-OHDA injection and could potentially be a way of determining 
immediate post-operative success in injecting this neurotoxin into the medial forebrain 
bundle.  An additional exploratory analysis was to compare the runners to the non-
runners in weight gain throughout the study.  It was thought that because of the 
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difference in activity level between the two groups there was a possibility that weight 
from the start of the study to the time of surgery may have been differentially affected.  
A 2 (time: pre and post) by 2 (group: runners and non-runners) mixed factorial ANOVA 
with weight as the dependent variable was used to explore this possibility. 
 
Figure 9.  Profound right neck turning immediately (within 20 minutes) after surgery for 
two of the rats. 
 
 
 
 
RESULTS 
 
Parkinsonian behavioral tests 
There was a statistically significant difference between the runners and non-
runners on apomorphine rotations, t(20) = 3.094, P = 0.006.  Animals that had run prior 
to the 6-OHDA lesion rotated significantly more than the non-runners had (Table 12, 
Figure 10). 
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Table 12.  Descriptive statistics of runners versus non-runners on apomorphine 
rotations. 
 Run status N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Apomorphine 
rotations 
Runners 12 306.5 115.772 33.421 
Non-runners 10 139.0 138.320 43.741 
 
 
Figure 10.  Apomorphine rotation box plot of runners versus non-runners. 
 
Figure 10.  Boxplot with medians, lower and upper quartiles, and smallest and largest 
observations of runners and non-runners on the number of apomorphine-induced 
contralateral rotations during a 30-minute testing period after 6-OHDA lesioning. 
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There was not a statistically significant interaction between group and time for 
forelimb placement asymmetry, F(1,16) = 0.680, P = 0.422 (ηp2 = 0.041, power = 0.121; 
Table 13).  The main effect of group was not significant (P = 0.639); however, the main 
effect for time was significant (P < 0.001).  Before the 4-week intervention, the rats were 
fairly symmetrical in forelimb arm use (runners = -0.02; non-runners = -0.01; Figure 11).  
One week after the 6-OHDA surgery, they were both fairly asymmetrical in their 
forelimb use with a preference for wall touches using the unimpaired forelimb 
regardless of treatment group (runners = 0.670; non-runners = 0.574; Figure 11). 
 
Table 13.  Descriptive statistics for forelimb placement asymmetry at the pre and post 
assessments. 
 time Mean Std. Deviation Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Runners Pre -.020 .128 .040 -.103 .064 Post .670 .230 .080 .502 .839 
Non-runners Pre -.005 .155 .056 -.123 .114 Post .574 .355 .112 .335 .812 
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Figure 11.  Forelimb placement asymmetry at the pre and post measurement times. 
 
 
Figure 11.  Means and standard deviations of the forelimb placement asymmetry ratio 
during a 10-minute period for runners and non-runners before and after 
implementation of the 4-week experimental treatment. 
 
There was not a statistically significant interaction between group and time for 
exploratory rearing, F(1,16) = .3.824, P = 0.068 (ηp2 = 0.193, power = 0.452; Table 14; 
Figure 12).  The main effect for group was not significant, p=.914; however, there was a 
statistically significant main effect for time with more exploratory rearing at the pre 
measurement (mean rears = 22.4, SE = 1.6) than the post measurement (mean rears = 
13.1, SE = 1.5), regardless of group, P < 0.001. 
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Table 14.  Descriptive statistics for exploratory rearing at the pre and post assessments. 
 
time Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Runners 
Pre 23.8 7.1 1.9 19.9 27.8 
Post 11.4 4.2 1.7 7.8 15.1 
Non-runners 
Pre 21.0 4.4 2.6 15.4 26.6 
Post 14.8 8.7 2.4 9.7 20.0 
 
 
Figure 12.  Graph of exploratory rearing at the pre and post measurement times. 
 
Figure 12.  Means and standard deviations of the number of exploratory rearing 
episodes during a 10-minute testing period for runners and non-runners before and 
after 4 weeks of treatment.  
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In the secondary exploratory analysis of the correlation between the other outcome 
variables and the immediate observation of right neck turning in the first 20 minutes 
after surgery, there were several moderate to high correlations (Table 15).  Of note, the 
right neck turn after surgery was strongly correlated with apomorphine rotations (r = 
0.734) and exploratory rearing (P = -0.749). 
 
Table 15.  Correlations of immediate right neck turning after surgery to the three 
behavioral tests. 
 Right neck 
turn after 
surgery 
Apo-
morphine 
rotations 
Forelimb  
asymmetry 
Exploratory 
rearing 
Right neck turn after surgery 1 .734** .534* -.749** 
Apomorphine rotations  1 .331 -.589* 
Forelimb asymmetry   1 -.511* 
Exploratory rearing    1 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
 
  
 In the secondary analysis of weight gain throughout the study, there was no 
significant interaction, which suggests that the running condition did not differentially 
affect weight gain, F(1,18) = 0.505, P = 0.486 (ηp2 = 0.027, power = 0.103; Table 16; 
Figure 13).  As expected, there was weight gain throughout the study for both groups, P 
< 0.001, from the pre measurement (weight = 406.5 grams, SE = 7.1, 95% CI: 391.6 – 
421.4) to the post measurement (weight = 455.1 grams, SE = 7.8, 95% CI: 438.7 – 471.4).  
There was also a main effect for group, P = 0.022, with the running rats weighing less 
(weight = 414.0, SE = 8.4, 95% CI: 396.3 – 431.8) than the sedentary control rats (weight 
= 447.5, SE = 10.3, 95% CI: 425.8 – 469.2). 
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Table 16.  Descriptive statistics for secondary analysis of weight gain throughout the 
study. 
 Time Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper Bound 
Runners 
Pre 392.1 30.8 9.0 373.3 410.9 
Post 436.0 40.3 9.8 415.3 456.7 
Non-runners 
Pre 420.9 31.5 11.0 397.8 443.9 
Post 474.1 20.9 12.0 448.8 499.4 
 
 
Figure 13.  Trajectory of weight gain over time for the runners and non-runners. 
 
 
Figure 13.  Means and standard deviations of the rats weighted in grams for runners and 
non-runners before and after 4 weeks of treatment. 
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DISCUSSION 
 
 Forced exercise prior to the onset of 6-OHDA-induced hemiparkinsonism in adult 
rats did not mitigate behavioral deficits.  Thus, rats who engaged in a regular forced 
running program were not protected from the neurotoxin 6-OHDA more than the 
sedentary non-runners in any of the behavioral tests.  In fact, it could be argued, based 
on the results of the apomorphine rotations, that non-runners were perhaps more 
protected than forced runners; however, taken together, these results clearly cast 
doubt on previous work that has shown a neuroprotective effect on PD (Cohen et al., 
2003; Faherty et al., 2005; Metz et al., 2004; Tillerson et al., 2002b).  Based solely on the 
results of the present study, the most logical conclusion is that a preconditioning of 
exercise is not neuroprotective; nevertheless, in context of the many studies that have 
demonstrated neuroprotection using this same model, the results of this study warrant 
a closer look at the methodology and design of this study’s exercise parameters and 
how they compare to the literature. 
Neuroprotection in a PD model due to a preconditioning of exercise was first 
documented by Cohen et al (2003) and Tillerson et al (2002) who found that forced 
nonuse (i.e., sedentary behavior) prior to 6-OHDA lesioning potentiated behavioral 
asymmetries (Cohen et al., 2003; Tillerson et al., 2002b).  In the Cohen et al (2003) 
study, which most closely approximates the present study in design, it was found that 
forced reliance on a forelimb prior to contralateral injection of 6-OHDA prevented 
behavioral asymmetries.  The forced reliance in the Cohen et al (2003) study, which has 
been equated to exercise, lasted for only 7 days prior to 6-OHDA lesioning and was 
61 
 
executed by casting the unimpaired forelimb in a retracted position to immobilize it, 
thereby forcing the animal to use the impaired forelimb for mobility, grooming, eating 
and all other tasks.  The dosing of this forced “exercise” was considerably more than the 
30 minutes per day for 5 days per week of forced treadmill running even when you 
consider that the length of treatment in the present study was 4 weeks.  Using a 
different PD model (i.e., mouse model using 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP)), Faherty et al (2005) used free access to a running wheel for 
several months (Faherty et al., 2005).  In the two studies that most closely resembled 
the present study, the dosing of exercise was considerably higher.  While the results of 
the present study suggest that preconditioning with exercise may not be 
neuroprotective, the lack of a positive treatment effect may be explained by the low 
dose of the exercise.  In light of this, further research using a more rigorous 
precondition of exercise is warranted. 
Another possibility for the lack of positive treatment effect from the 
preconditioning of exercise is deleterious stress.  Smith et al (2002) hypothesized that 
stress might be a key factor in the loss of dopaminergic neurons that underlie the 
pathology of PD (Smith et al., 2002).  They based this hypothesis on the following lines 
of evidence:  1. stress has been shown to increase PD symptoms in humans; and, 2. 
animal PD models have shown that stress is deleterious and cancels out the positive 
treatment effect of exercise.  Smith et al (2002) reported that animals subjected to 
restraint stress and then immediately injected with 6-OHDA demonstrated significantly 
greater behavioral impairments than animals that were just injected with 6-OHDA.  They 
62 
 
argue that this stress may actually increase the vulnerability of dopaminergic neurons to 
subsequent insult, a phenomenon that Sapolsky termed “neuroendangerment” 
(Sapolsky, 1992).  Howells et al (2005) provided validity to this notion by demonstrating 
that mild stressors were able to cancel out the neuroprotective effects of voluntary 
exercise in 6-OHDA-lesioned animals (Howells et al., 2005).  In addition, others have 
demonstrated that stress increases motor impairments in the 6-OHDA model (Snyder et 
al., 1985).  In the present study, rats were exposed to a forced exercise regimen during 
the light cycle which is not a not a typical time for increased activity and is, therefore, a 
potential mild stressor.  In addition and perhaps more stressful, the rats were forced to 
run on a treadmill with an aversive electrical stimulus.  When the rats would stop 
running or were non-compliant with running they would receive an unpleasant electrical 
shock.  While most rats learned quickly, the occasional slowing on the treadmill was a 
quick reminder that a painful shock was ever present.  This may have created a stressful 
milieu and may have negated the neuroprotective effect of exercise.  A more 
sophisticated research design would be necessary to verify this assertion. 
In the secondary analysis on weight gain, all of the rats increased weight from 
the start of the study to just before the 6-OHDA lesioning.  This suggests that the forced 
running did not differentially slow weight gain compared to the sedentary non-runner 
group.  Since the rats were fed ad libitum, the logical supposition is that the increase in 
physical activity was met by a concomitant increase in food intake.  However, the main 
effect for group does indicate that the forced runners did not weigh as much as the non-
runners.  However, closer inspection shows that the runners started out lighter and 
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finished lighter than the non-runners; the trajectory of their weight gain was the same 
as the non-runners so it is not likely that differential weight gain may have played a role 
in the motor impairment (Figure 19).  In addition, because the weights of the animals 
were all within a relatively tight range, the stereotactic coordinates for the 6-OHDA 
injections were the same and not likely to be affected by differences in animal or head 
size. 
It was noted that during recovery shortly after the 6-OHDA injections (before the 
rats had achieved full consciousness) that many of the rats would start to turn their neck 
sharply to the right (Figure 15).  Because this was an unusual post-surgical presentation 
for an animal and because it was ipsilateral to the 6-OHDA lesion, the presence of this 
right sidebending was recorded for further analysis as a potential indicator of lesion 
severity.  The results of this analysis indicate that this immediate right neck turning was, 
in fact, related to the severity of the lesion with significant point biserial correlations for 
all three of the behavioral tests with the highest correlations for apomorphine rotations 
and exploratory rearing (Table 15).  Based on these results, it appears that the 
immediate right neck turning is an early indicator of the 6-OHDA injection success.  In 
light of these findings, further assessment of right neck turning after 6-OHDA injection 
as a possible immediate behavioral indicator of successful placement into the medial 
forebrain bundle is warranted. 
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CONCLUSION 
A preconditioning of regular forced exercise did not protect 6-OHDA-induced 
hemiparkinsonian behavioral asymmetry prior to the onset of the lesion in adult rats.  
These results are not consistent with previous data that has shown a neuroprotective 
effect of forced exercise on subsequent neurotoxic insult and cast doubt about the 
validity of these previous findings.  In light of the present results, further research is 
warranted. 
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CHAPTER 4 
 
A comparison of voluntary and forced exercise in driving neuroprotection of 
nigrostriatal pathways in a juvenile hemiparkinsonian rat model 
 
Abstract:  Several studies have found a neuroprotective effect of forced exercise in 
rodent Parkinson’s disease models; however, the evidence for the protective effect of 
voluntary exercise is mixed.    Most of these studies have initiated the exercise after 
toxin-induced hemiparkinsonism.  Few studies have investigated the role of a 
preconditioning of exercise prior to neurotoxic insult.  Therefore, the purpose of this 
study was to explore the neuroprotective effect of regular forced and voluntary exercise 
in recently weaned rat pups prior to an adult hemiparkinsonian lesion.   Recently 
weaned rat pups were randomized into four 6-week experimental groups:  forced 
exercise, voluntary exercise, control, and a sham surgery control.  After participation in 
a 6-week experimental condition, hemiparkinsonism was induced using a unilateral 
injection of 6-hydroxydopamine (6-OHDA).    Parkinsonian behavioral tests (i.e., 
apomorphine rotations, forelimb placement asymmetry, exploratory rearing) 
demonstrated significant motor asymmetry for all three 6-OHDA group; however, there 
were no significant differences among them.  The sham control rats did not show motor 
impairment consistent with nigrostriatal motor deficits.  Neither a preconditioning of 
forced nor voluntary exercise was neuroprotective of a future 6-OHDA lesion.  These 
results are in contrast the literature and challenge the validity of these previous studies. 
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INTRODUCTION 
Exercise produces a plethora of benefits in those who have been diagnosed with 
Parkinson’s disease (PD) (Crizzle & Newhouse, 2006; Goodwin et al., 2008; M. A. Hirsch 
& Farley, 2009).  In fact, many national and international panels on the topic have 
recommended the use of exercise to improve outcomes, activities of daily living and 
motor performance in those with PD (Horstink et al., 2006; Keus et al., 2007; 
Suchowersky et al., 2006b).  Others have suggested the type of exercise is an important 
prescriptive consideration in PD (Ridgel et al., 2009).  While these studies collectively 
suggest that functional outcomes are indeed improved with general exercise, they add 
little knowledge as to how exercise and different exercise parameters influence the 
underlying disease processes of PD.  For this reason, studies using comparative-control 
designs with animal models of PD are needed to explore these relationships. 
In animal models, there are two different exercise modalities, forced exercise 
and voluntary exercise.  While several studies have found a neuroprotective effect on 
PD with forced exercise (Cohen et al., 2003; Tillerson et al., 2002a, 2003; Tillerson et al., 
2001), the results with voluntary exercise are not as well developed.  O’Dell et al (2007) 
found that voluntary wheel running facilitated motor recovery following toxin-induced 
PD but does so without sparing of dopamine terminals (O'Dell et al., 2007).  Mabandla 
et al (2004) found that voluntary running using the same PD model did prevent 
apomorphine-induced contralateral rotations suggesting a sparing of dopaminergic 
neurons (Mabandla et al., 2004).  Much like forced exercise, these latter two studies 
suggest that voluntary exercise may also offer some benefit in rodent models of PD. 
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One of the key differences between these two exercise modalities is that 
voluntary exercise allows the animal freedom to choose the timing and dosage of the 
exercise, whereas forced exercise removes this aspect and usually relies on an aversive 
stimulus to condition the behavior.  In the case of rat forced exercise models, this 
usually means an electrical grid on the back of a rodent treadmill that administers an 
electrical shock should the rat slow down or stop running.  Unpleasant “encounters” 
with the electrical grid due to running noncompliance is what conditions running 
behavior.  While this aversive stimulus is effective at conditioning running behavior, it 
can create a stressful atmosphere for the animal.  Voluntary running occurs when the 
animal decides, usually in the dark cycle; whereas, forced running usually occurs during 
the light cycle for researcher convenience.  The light cycle is typically a time of less 
activity for the animal and so it is plausible that this may add to the already stressful 
environment of forced running.  Importantly, stress has received traction in the 
literature as a key factor in the loss of dopaminergic neurons that underlies PD (Smith et 
al., 2002).  In support of this notion, Howells et al (2005) demonstrated that even mildly 
stressful conditions can negate the neuroprotective effect of exercise in a rat model of 
PD (Howells et al., 2005). 
A recent review from the literature (Ang & Gomez-Pinilla, 2007) suggests that 
forced exercise and voluntary exercise have different effects on brain neurochemistry 
and behavior.  Leasure and Jones (2008) found that rats in a forced exercise condition 
ran about the same distance as rats that voluntarily exercised (Leasure & Jones, 2008).  
However, they report that voluntary exercise rats ran faster and for less total time than 
68 
 
rats that were forced.  Additionally, they found that rats in the forced exercise condition 
exhibited more anxiety-like behaviors compared to the voluntary exercisers despite the 
fact that there was no difference in corticosterone between the two groups.  Leasure 
and Jones (2008) further suggest that it is imperative that neural and behavioral effects 
of different forms of exercise using the similar parameters need to be addressed in 
greater detail scientifically (Leasure & Jones, 2008).   
Almost all of the aforementioned studies on the effect of exercise 
neuroprotection have administered the experimental exercise condition after the onset 
of toxin-induced PD.  Some would argue that this is not technically neuroprotection but 
rather neuroplasticity of undamaged dopaminergic neurons.  While the convention is to 
use the term “neuroprotection,” it is not technically correct; neuroprotection is 
technically something that protects nerves from future insult, not a “treatment” 
administered after the onset of the disease.  Few studies have used a true 
“neuroprotection” design, wherein an exercise program was administered to rats before 
a 6-OHDA-induced PD (Cohen et al., 2003; Mabandla et al., 2004; O'Dell et al., 2007).  
While the designs of these studies certainly makes sense from a neuroprotective 
perspective, they may not capture the true neuroprotective effect of exercise 
throughout the life of the animal as they were all administered to adult rats.  For this 
reason, the purpose of this study was to explore the neuroprotective effect in terms of 
parkinsonian behavioral signs of regular forced and voluntary exercise in recently 
weaned rat pups until they received an adult, neurotoxin-induced PD lesion.  
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METHODS 
Overall study design 
Thirty-eight male recently weaned Long Evans rats (Charles River Laboratories, 
California, USA) were randomized into one of four different experimental groups prior 
to induction of hemiparkinsonism using an injection of the dopaminergic neurotoxin, 6-
hydroxydopamine hydrochloride (6-OHDA).  The four experimental groups each lasted 6 
weeks and consisted of the following: forced exercise, voluntary exercise, control, and 
sham surgery control (Figure 14).  The original randomization allocation was 10 rats to 
each of the experimental groups and 6 to the sham group.  Because two additional rats 
were delivered by Charles River Laboratories, randomization was changed to a stratified 
randomization plan wherein the two additional rats were allocated to the forced 
exercise group since attrition from non-compliance with forced running has been a 
concern in previous studies conducted by this investigator; therefore, it was felt that a 
few extra animals in the forced running group would help in the case of drop out from 
running non-compliance.  After the 6-week experimental treatment and 6-8 days 
following 6-OHDA lesioning, neuroprotection was tested using three different motor 
behavioral tests (forelimb asymmetry, apomorphine rotations, exploratory rearing). 
Rats were housed individually, fed ad libitum, and housed under standard 
laboratory conditions with a 12 hour light/dark cycle.  All experimental conditions were 
approved by the University of Nevada, Las Vegas Institutional Animal Care and Use 
Committee and were consistent with the National Institute of Health Guide for the Care 
and Use of Laboratory Animals.   
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Experimental conditions   
Group 1 (forced exercise) was a 6-week regimen (5 days per week with 2 bouts 
of 15 minute periods per day starting at a speed of 8 m/min (Kuo et al., 2010) for two 
weeks and ultimately progressing to 15 meters/minute for the last 4 weeks (Tillerson et 
al., 2003) using a rodent treadmill with three running lanes (Exer 3/6 Treadmill, 
Columbus Instruments, USA); generally, three rats ran concurrently.  The treadmill was 
equipped with an electrical grid at the back end of the belt that would elicit an aversive 
electrical stimulation upon contact with the tail or hind limbs of rats that had slowed or 
were noncompliant with running.  Once rats were conditioned to the aversive electrical 
stimulus, the intensity of the stimulus was turned down so that any incidental contacts 
with the tail would not result in a strong electrical shock.  In most cases, the stimulus 
intensity was turned down to imperceptible levels.   
Group 4: 
Sham 
6 rats 
38 male – 75-100 
gram Long-Evans 
rats 
Motor behavior tests:  
• Forelimb placing asymmetry 
• Apomorphine rotations 
• Forelimb exploratory rearing 
Group 3: 
Control 
10 rats 
Group 1: 
Forced exercise 
12 rats  
6-OHDA surgery 
 
Group 2: 
Voluntary exercise 
10 rats 
Figure 14.  Overall study design. 
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Group 2 (voluntary exercise) was a 6-week regimen of voluntary exercise.  These 
rats were housed singly in a plastic housing container that had an attached running 
wheel with a revolution counter.  Running wheel revolutions were recorded daily to 
determine the overall dosing of exercise.  Group 3 (no exercise) was the non-exercise 
control group.  These control rats were housed singly for six weeks with no running 
wheel and no other opportunities to exercise or run.  Group 4 (sham) was essentially the 
same as Group 3 in terms of housing and exercise; however, sham rats received a saline 
injection instead of 6-OHDA during the stereotactic surgery.  All other surgical 
procedures for the sham group were identical to the other three groups. 
 
Surgical procedures 
After the 6-week experimental treatment, all rats had a neurosurgerical injection 
into their nigrostriatal fibers.  The first three groups (except Group 4) had a 6-OHDA 
neurotoxin injection into the right medial forebrain bundle.  Animals were anesthetized 
using an intraperotoneal injection of 75 mg/kg Ketamine and 0.25mg/kg 
dexmedetomidine.  After the animal had achieved surgical anesthesia, they were shaved 
and then moved to the stereotactic frame (Kopf 900, David Kopf Instruments, Tujunga, 
California, USA).  The head was placed into the frame using ear bars which were placed 
into the ear canals.  Once the head was symmetrically placed in the frame, the incisor 
bar was placed and the nose clamp was tightened.  Eye ointment (GenTeal 0.3% eye gel, 
USA) was placed on the eyes and the incision site on the head was generously swabbed 
with povidone-iodine topical antiseptic.  A heating pad was placed under the rat to keep 
72 
 
in warm during the procedure.  Following a longitudinal incision to expose the skull and 
bregma, a small 1-mm burr hole was drilled through the cranium with a mounted dental 
drill to gain exposure to the cranial cavity using the following coordinates: 3.3 mm 
posterior to bregma, 1.9 mm lateral to the midline (Paxinos & Watson, 1998; Paxinos et 
al., 1985; Tillerson et al., 2003; Tillerson et al., 2002b).  A 28-guage, 5 μl-microliter 
syringe (Hamilton, Reno, Nevada, USA) was then plunged into the burr hole 8.2 mm 
ventral to the skull surface and 10μg of 6-hydroxydopamine hydrobromide (10 μg/4μl 
0.155 M sterile NaCl containing 0.2 μg/μl ascorbic acid; Sigma, St. Louis, MO)(Howells et 
al., 2005; Mabandla et al., 2004) in 4 μl of 0.9% saline was injected at a rate of 1 μl/min 
for 4 minutes (Mabandla et al., 2004; Moroz et al., 2004; Tillerson et al., 2003; Tillerson 
et al., 2002b) into the right medial forebrain bundle  which contains the dopaminergic 
nigrostriatal fibers. 
The burr hole was closed using bone wax and the incision was sutured with 5-6 
sutures using simple interrupted suture patterning.  The incision was swabbed in 
povidone-iodine antiseptic once more to prevent postsurgical wound infection.  The 
entire neurosurgical procedure did not exceed 45 minutes.  After removal from the 
stereotactic frame, rats were brought out of surgical anesthesia using atipamezole, a 
dexmedetomidine reversal agent, at 1 ml/kg (subcutaneous).  After approximately 10-20 
minutes, the rats were out of anesthesia and mobile on all fours. However, they were 
observed for another hour before they were moved back to their plastic housing units.  
To manage postoperative pain, rats were then injected with 0.01 mg/kg (subcutaneous) 
buprenorphine into the flank shortly after ambulatory on all fours.  They received this 
73 
 
same injection for the next three days.  There were no surgery-related animal deaths or 
any postsurgical infections in any of the animals in this study. 
 
Motor behavior tests 
After 6-8 days post-6-OHDA injection, all of the animals were tested for the 
severity of the disease (apomorphine rotations), the severity of their motor asymmetry 
(forelimb placement asymmetry), and the extent of their hypokinesia or paucity of 
movement (exploratory rearing).  During this 6-8 day period, the rats in the two exercise 
groups continued with their same exercise regimen.  The rats in the forced exercise 
condition began treadmill exercise within 24 hours of the hours of the lesion but were 
run only once for the first two days after the lesion.  For the next 4-6 days, they 
returned to their twice per day exercise protocol.  The voluntary exercise rats were 
returned to their plastic housing units and were given free access to the running wheels. 
Apomorphine rotations.  Apomorphine rotations were evaluated by a 
subcutaneous injection of 0.5 mg/kg apomorphine hydrochloride (Sigma, St. Louis, USA) 
dissolved in saline in the dorsal right quadrant proximal to the pelvis (Joghataie et al., 
2004; Mabandla et al., 2004; Roghani & Behzadi, 2001; Tillerson et al., 2002b).  
Apomorphine rotations are thought to be due to 6-OHDA-induced denervation of the 
right medial forebrain bundle; this causes the dopamine receptors in the right striatum 
of the basal ganglia to become hypersensitive due to the paucity of dopamine relative to 
the contralateral side.  Apomorphine stimulates receptors on both sides (i.e., the 
affected and unaffected basal ganglia) but because the receptors on the right (affected) 
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are hypersensitive the outcome is a relative increase of right striatal activity compared 
to the contralateral side.  Since the right striatum of the basal ganglia influences motor 
behavior on the contralateral side (left side), this causes a rapid, repetitive turning of 
the body away or contralateral (i.e., to the left) from the lesioned side.  The number of 
times the animal rotated 360° in each direction over a 30-minute period was counted at 
a later time using a videotaped recording that was taken from above the animal during 
the 30-minute period.  Ipsilateral rotations subtracted from the number of contralateral 
rotations resulted in a net number of contralateral rotations (Poulton & Muir, 2005).  
Complete 360° rotations within 30 minutes in a round bowl have been shown to 
correlate with PD lesion severity (Hudson et al., 1993; Metz & Whishaw, 2002).  In 
addition, it has been reported that a rat which turns more than 200 times in a 30 minute 
period has had a 95% depletion of striatal dopamine (Schwarting & Huston, 1996).  
Since apomorphine rotations are directly related to the severity of the dopaminergic 
attrition, this test has been recognized as a surrogate for severity of the nigrostriatal 
neurotoxin-induced damage.  It has been used as a motor outcome measure in nearly 
every exercise study that has used the 6-OHDA PD model. 
Forelimb placement asymmetry.  Forelimb asymmetry was evaluated first by placing 
the animals in a plastic cylinder (22cm wide by 26 cm high) for 10 minutes and then by 
videotaping from above their behavior over that time.  As the animal would rear for 
exploration, the number of initial forelimb touches to the walls of the cylinder (i.e., 
impaired left forelimb first, unimpaired right forelimb first, simultaneous) for each 
individual exploratory rearing episode was recorded (Moroz et al., 2004; O'Dell et al., 
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2007; Poulton & Muir, 2005; Schallert & Tillerson, 1999; Tillerson et al., 2003; Tillerson 
et al., 2002b).  The wall touches were recorded and the asymmetry ratio was calculated 
using the following:  (Right-Left)/(Right+Left+Both)(O'Dell et al., 2007).  Scores on the 
forelimb asymmetry ratio range from -1 to 1 with a high positive indicative of 
asymmetry favoring the unimpaired forelimb.  A negative asymmetry ratio would be 
indicative of greater left or impaired forelimb usage.  Thus, a high positive forelimb 
placement asymmetry ratio (i.e., greater right, unimpaired forelimb use) would be 
consistent with a right 6-OHDA-induced hemiparkinsonian lesion.  
Exploratory rearing episodes.  Each episode of exploratory rearing was counted over 
the 10 minute videotaped session that was used for forelimb placement asymmetry.  
This has not been documented previously in the literature but significant correlations 
with the other behavioral tests in Chapter 3 suggest that it may offer some value in 
motor behavior; it was felt that exploratory rearing was a logical test for a common 
symptom in PD, hypokinesia (i.e., paucity of movement). 
 
Data analysis 
All analyses were conducted using SPSS version 19.0 (IBM SPSS, Chicago, Illinois, 
USA).  In order to determine if there was a difference among the four experimental 
groups (forced exercise, voluntary exercise, control, and sham control), a one way 
analysis of variance (ANOVA) was conducted for each of the three behavioral tests 
(apomorphine rotations, forelimb placement asymmetry, and exploratory rearing) that 
were conducted immediately after the 6-week treatment ended (Figure 14).  When 
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significant violations of assumptions occurred than non-parametric equivalents were 
used in lieu.  In an exploratory secondary analysis, spearman correlations were 
conducted for the immediate post-surgical observation (i.e., within 20 minutes) of right 
neck turning (0 = no neck turn, 1 = delayed and mild neck turn, 2 = delayed but profound 
neck turn, 3 = early and severe neck turn) to the three other behavioral tests in the 
study (Chapter 3; Figure 9).  Significant correlations of this were found in study 2 of this 
dissertation (Chapter 3; Table 15).  As this has been the only line of evidence to suggest 
that this immediate post-operative phenomenon may be related to 6-OHDA 
nigrostriatal neurotoxic damage, this observation was again noted in this study for 
exploratory analysis.  Data in the present study were also analyzed using point biserial 
correlations (similar to Chapter 3 results) to see if the correlations were in the same 
range as Chapter 3 results; immediate post-surgical right neck turning was dichotomized 
(1 = no or mild neck turn, 2 = profound neck turn) and reanalyzed using correlations 
among the three behavioral tests with point biserial correlations.  An additional 
exploratory analysis was to compare the weight of the four groups during the 
experimental treatment.  It was thought that because of the difference in activity level 
among the four groups there was a possibility that a significant difference in 
weight/growth may have been a threat to internal validity as the stereotactic 
coordinates would have been different for different size animals.  This analysis was 
conducted using an 8 (time: 7 preoperative measurements, 1 postoperative 
measurement at the time of surgery) by 4 (group: forced, voluntary, control, sham) 
mixed factorial ANOVA.  The last exploratory analysis was a comparison between the 
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two exercise groups on the dosing of exercise.  This was done by comparing the average 
daily distance ran in meters and comparing the preoperative treatment with the 
postoperative treatment using a 2 (group: forced and voluntary) by 2 (time: 
preoperative average and postoperative average) mixed factorial ANOVA. 
 
RESULTS 
Primary analyses 
 Because of a violation of homogeneity of variance (P = 0.05) coupled with 
unequal group sizes, a Kruskal-Wallis non-parametric test was run for the apomorphine 
data.  There was a statistically significant difference among the medians of apomorphine 
rotations, H(3) = 9.754, P = 0.021.  Pairwise comparisons were run using the 
nonparametric Mann-Whitney test.  All three of the groups that had the 6-OHDA 
injection (i.e., voluntary, forced, control) rotated significantly more than the one group 
that had a saline injection (i.e., sham), Ps ≤ 0.018 (Table 17, Figure 15).  There were no 
differences in apomorphine rotations among the three groups that had the 6-OHDA 
injection, Ps ≥ 0.111. 
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Table 17.  Apomorphine rotation descriptive statistics for the forced, voluntary, control 
and sham groups. 
 N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Apomorphine 
rotations 
Forced 12 131.3 93.3 26.9 72.07 190.60 
Voluntary 9 75.0 74.8 24.9 17.50 132.50 
Control 10 90.6 74.3 23.5 37.44 143.76 
Sham 6 -11.5 14.4 5.9 -26.59 3.59 
 
 
Figure 15.  Boxplot of apomorphine rotations for the forced, voluntary, control and 
sham groups. 
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Figure 15.  Means and standard deviations for the number of apomorphine-induced 
contralateral rotations during a 30-minute testing period for runners and non-runners 
before and after 4 weeks of experimental treatment. 
  
There was a statistically significant difference among the means for the four 
groups for forelimb placement asymmetry, F(3,37) = 8.509, P < 0.001.  Tukey pairwise 
comparisons revealed that the three groups that had the 6-OHDA injection had 
significantly more forelimb asymmetry than the sham group, Ps ≤ 0.001 (Table 18, 
Figure 16).  The forelimb asymmetry was essentially the same for the three 6-OHDA 
groups, Ps ≥ 0.909. 
 
Table 18.  Forelimb placement asymmetry descriptive statistics for the forced, 
voluntary, control and sham groups.  
 N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Forelimb 
placement 
asymmetry 
Forced 12 -.703 .385 .111 -.9477 -.4586 
Voluntary 10 -.793 .194 .061 -.9316 -.6536 
Control 10 -.776 .385 .122 -1.0514 -.5011 
Sham 6 -.057 .084 .034 -.1447 .0305 
 
80 
 
 
Figure 16.  Boxplot of forelimb placement asymmetry for the forced, voluntary, control 
and sham groups. 
 
Figure 16.  Means and standard deviations for the forelimb placement asymmetry ratio 
during a 10-minute testing period for runners and non-runners before and after 4 weeks 
of experimental treatment. 
 
 The number of exploratory rears in a 10 minute period was not the same for all 
four of the experimental groups, F(3,37) = 6.436, P = 0.001.  The number of exploratory 
rears was similar among the three groups that had the 6-OHDA injections, Ps ≥ 0.842; 
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however, each of these three 6-OHDA injection groups had fewer rearing episodes than 
the sham lesion group, Ps ≤ 0.008 (Table 19, Figure 17). 
 
 
Table 19.  Exploratory rearing descriptives for the forced, voluntary, control and sham 
groups. 
 N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Exploratory 
rearing 
Forced 12 23.2 13.9 4.0 14.3634 31.9699 
Voluntary 10 18.7 13.2 4.2 9.2816 28.1184 
Control 10 20.0 9.9 3.1 12.8863 27.1137 
Sham 6 45.0 13.1 5.4 31.2048 58.7952 
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Figure 17.  Boxplot of exploratory rearing for the forced, voluntary, control and sham 
groups. 
 
Figure 17.  Means and standard deviations of the number of exploratory rearing 
episodes during a 10-minute testing period for runners and non-runners after 6 weeks 
of the experimental conditions. 
 
Secondary analyses 
Significant Spearman correlations were observed for the immediate post-surgical 
observation of right neck turning to the three other behavioral tests in the study (Table 
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20).  The values for the correlations among the three behavioral tests in Table 20 are 
Spearman’s correlations.  The point biserials of the dichotomized neck turning to the 
behavioral tests were the following:  apomorphine rotations (r = 0.480), forelimb 
placement asymmetry (r = -0.357), and exploratory rearing (r = -0.479). 
 
Table 20.  Spearman correlations for right neck turn after surgery of the three 
behavioral tests.   
 
Right neck 
turn after 
surgery 
Apo-
morphine 
rotations 
Forelimb 
asymmetry 
Exploratory 
rearing 
Right neck turn after surgery 1 .492** -.363** -.363** 
Apomorphine rotations  1 -.633** -.383* 
Forelimb asymmetry   1 .444** 
Exploratory rearing    1 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
 
 
The weight of the recently weaned rats increased significantly over the course of 
the trial, p<.001; however, there was no difference in the rate of weight gain among the 
four groups over time, F(21,238) = 1.810, P = 0.100, power = 0.682 (Table 21, Figure 18).   
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Table 21.  Weight gain for all of the rats over the course of the study. 
time Mean Std. Deviation Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Pre 53.8 6.1 0.9 52.0 55.7 
1 117.8 13.1 2.2 113.3 122.2 
2 167.7 14.3 2.3 163.0 172.5 
3 214.0 18.1 3.0 207.8 220.1 
4 264.6 18.5 2.9 258.7 270.5 
5 298.6 21.9 3.7 291.1 306.1 
6 328.0 25.6 4.0 319.9 336.2 
Post 323.8 31.7 5.1 313.4 334.2 
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Figure 18.  Weight gain for each of the four treatment groups over the duration of the 
study. 
 
Figure 18.  Means and standard deviations of the weight in grams of the rats in the four 
experimental conditions at each of the 6 weeks preceding the 6-OHDA lesion and one 
week after the lesion. 
 
In terms of the difference between the two exercise groups, voluntary and 
forced, in the average number of meters ran per day, the voluntary group ran 
significantly more than the forced group before and after the surgery, P < 0.001 (Figure 
19). 
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Figure 19.  Average distance ran in meters for the 6 weeks pre surgery and the 1 week 
post-surgery for the voluntary and forced exercise groups. 
 
Figure 19.  Means and standard deviations of the average distance ran in meters in the 
forced and voluntary exercise conditions in the 6 weeks before and the one week after 
the 6-OHDA lesioning. 
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Figure 20.  Average daily distance in meters ran for each rat in the voluntary running 
group. 
 
Figure 20.  Means of the distance ran in the 6 weeks of voluntary exercise for each of 
the rats in the voluntary exercise group. 
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Figure 21.  Daily totals in running wheel clicks over the 6 weeks of voluntary running and 
the one week after running. 
 
Figure 21.  Daily means of the distance ran for each of the rats in the voluntary running 
group showing the increase in trajectory of running during the 6 weeks prior to 6-OHDA 
lesioning. 
 
DISCUSSION 
 While previous research has provided several lines of evidence that exercise in 
rodent models of PD is neuroprotective, the results of the present study do not support 
this notion.  In addition, it has been demonstrated that neither forced nor voluntary 
running affords neuroprotection in 6-OHDA-induced hemiparkinsonian rats.  Despite the 
novel design element of introducing the exercise shortly after weaning, which would be 
akin to exercising throughout life, there was no evidence that exercise provided 
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neuroprotection from 6-OHDA-induced behavioral asymmetry.  These results are in 
contrast to the body of literature on exercise neuroprotection in PD and cast doubt on 
the validity of the notion that exercise is neuroprotective in PD. 
 Several human studies have shown that greater baseline exercise in early life is 
associated with a lower risk of PD (Chen et al., 2005; Sasco et al., 1992; Tsai et al., 2002).  
This exercise occurred before PD diagnosis and presumably before the pre-clinical phase 
had begun.  This was an important consideration in the casting of the design of the 
present study.  Namely, that implementation of a putative neuroprotective treatment 
should happen before the onset of the disease rather than after the fact on while the 
disease is in process.  All of the previous work using a true neuroprotective design (i.e., 
exercise implemented before the neurotoxic lesion) had staged the implementation of 
the exercise to rats who were physically mature adults.  Since neurodevelopment is 
most robust in young and adolescent brains, it was felt that an important 
neuroprotective window of opportunity may have not been appropriately vetted 
scientifically.  Thus, in the present study, exercise was implemented shortly after 
weaning and continued for 6 weeks, which would be well into the maturity of the 
animal.  From a design perspective, the implementation of the exercise shortly after 
weaning was novel; however, the results of this study did not show any positive 
neuroprotective benefit from exercise throughout the post-weaned lifespan of the 
animal. 
 One of the premises of the study was that forced running, because of an aversive 
electrical stimulus, would be traumatic to the animal and that this would create a 
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stressful milieu that would reduce the neuroprotective effect of exercise as was shown 
in the Howells et al (2005) study (Howells et al., 2005).  In accordance with Howells et al 
(2005), Smith et al (2002) hypothesized that stress may actually endanger dopaminergic 
neurons, thereby potentiating dopamine attrition (Smith et al., 2002).  Thus, this study 
was designed with a comparative-control design that would hopefully clear up the 
hypothesis that exercise was truly neuroprotective; the other main premise of the 
study.  Two exercise modalities, forced (i.e., stressful) and voluntary (i.e., non-stressful), 
were compared to a no exercise control and a no exercise sham control.  If stress was 
indeed deleterious and if exercise was neuroprotective, then we would have expected 
to see the voluntary running group with forelimb placement symmetry similar to or 
close to the sham group and the forced running group with behavioral asymmetry 
similar to or close to the no exercise control group.  Neither of these happened in the 
present study.  Instead, there were no statistically significant differences among the 
forced running, voluntary running and control for any of the motor behavior tests 
suggesting no treatment effect of the exercise and no deleterious effect in the 
“stressful” forced running group.  These three groups did have significantly more 
behavioral asymmetry than the sham group which suggests that they all had significant 
motor signs and asymmetry consistent with the 6-OHDA-induced PD model.  Based on 
the results of this study, neither of the two main premises (i.e., exercise is 
neuroprotective, forced exercise is deleterious) of this study were upheld. 
Since there appears to be differences in the means of all three behavioral tests 
(not statistically significant) that are somewhat consistent with exercise being 
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neuroprotective (Figure 15-17), it is plausible that a type 2 error may have occurred 
since the study was clearly underpowered.  That is, exercise may be neuroprotective but 
the treatment effect was so small that it would require a much larger sample size to 
realize a statistically significant difference.   Using the effect size indices in the present 
study (apomorphine rotations f = 0.309; forelimb placement asymmetry f = 0.124; 
exploratory rearing f = 0.161) and 80% power estimate, it would require the following 
approximate sample sizes for differences to become statistically significant for the two 
exercise groups and the control (sham was not factored into the estimate):  
apomorphine rotations (36 rats per group; 108 rats total); forelimb placement 
asymmetry (322 rats per group; 966 rats total); and, exploratory rearing (144 rats per 
group; 432 rats total).  Based on the results of the present study, either there is no 
treatment effect at all (i.e., exercise is not neuroprotective) or there is only a small 
treatment effect (i.e., mildly neuroprotective).  The latter would represent a type 2 error 
since we did not find a statistically significant difference among the three 6-OHDA 
lesioned groups; however, powering a study to verify this would be implausible with 
sample size estimates ranging from 108 to 966 total rats needed.  Moreover, the risk-to-
benefit ratio in light of animal mortality would not be warranted given the mild 
treatment effect. 
 One of the expectations of this study was that the rats in the voluntary running 
group would run more on their running wheel than the forced running group would on 
the treadmill.  What was not expected, however, was how much more the voluntary 
running group would run.  On average, the voluntary running rats ran more than 3.5 
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kilometers per day before the 6-OHDA lesion, whereas the forced rats averaged less 
than 500 meters per day before the 6-OHDA lesion, almost a seven fold difference in the 
dosing of exercise (Figure 19).  Clearly the forced exercise group could have tolerated 
more exercise; however, this would have been difficult considering the man power 
necessary to the run the animals for that length of time (i.e., at least 3.5 more daily 
hours per rat).  In addition, after the 6-OHDA lesion in the week before the last motor 
behavior test, the voluntary rats ran on average 10 times more than the forced rats in 
the same period, >2,000 meters and <200 meters per day, respectively.  If exercise was 
truly neuroprotective, then a dose dependent neuroprotective relationship in the motor 
behavior tests would have likely been observed.  That is, if exercise was beneficial, it 
would have been expected that the forced running group would have less motor 
impairment than the no exercise control group and an even greater amelioration of 
motor impairment in the voluntary running group.  Since this clearly did not happen in 
the present study, the logical conclusion is that exercise does not afford a 
neuroprotective benefit. 
 The trajectory of voluntary running over the course of the study (6 weeks pre-
lesion and 1 week post-lesion) show a gradual increase in running over time until the 6-
OHDA lesioning and a decrease after surgery (Appendix, Figure 20).  Thus, as the rats got 
older and more acclimatized to the running wheel they began to run more.  This is not 
fully consistent with Peng et al (1980) who demonstrated that rats decrease running 
activity as they age (Peng et al., 1980); though, it should be noted that the rats in that 
study were older than the rats in the present study when they started their running.  
93 
 
Whether they were running faster or for longer durations or both in comparison to the 
forced exercise group is not known as this was not specifically tracked.  As rats are 
nocturnal, it is not surprising that the majority of their running episodes occurred in the 
dark cycle.  Unfortunately, this too was not documented; however, qualitatively, it was 
the observation of the research team that the rats did not run during the day and this is 
consistent with the literature which shows running activity is about 80% nocturnal (Peng 
et al., 1980).  The volume of the running in the voluntary group was also remarkable 
(Appendix, Figure 21).  Five of the ten rats averaged more than 4 kilometers of running 
per day and one of these averaged 7 kilometers per day.  The rat that ran the least still 
ran more than twice the average distance of the forced exercise rats.  While the 
distances in voluntary running seem quite high, rats are known to be fairly prodigious 
voluntary runners with one documented case as high as 43 kilometers in a 24 hour 
period (Richter, 1927).  Since rats are clearly capable of much greater distances than 
forced treadmill exercise protocols permit and since forced exercise typically uses 
aversive stimuli to condition the running the running behavior, it is recommended that 
this approach to exercise in rodents become obsolete. 
 The secondary analysis of the correlation between the immediate post-operative 
observation of right neck turning and the motor behavioral tests conducted a week later 
suggests that this observation is indeed related to the severity of the neurotoxic 6-
OHDA lesion (Table 20).  The more profound the right neck turns immediately after 
surgery, the more apomorphine rotations, the higher the preference for use of the 
unimpaired forelimb, and the fewer exploratory rearing episodes.  Based on these 
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findings, this novel observation, that has not been previously reported in the literature, 
can be used as an immediate indicator of successful placement of the neurotoxin 6-
OHDA in the medial forebrain bundle.  The fact that this observation begins almost 
immediately (within 10-15 minutes) post-operatively suggests that this neurotoxin has 
an almost immediate damaging effect on the nigrostriatal fibers.  However, it is known 
that 6-OHDA toxicity may be quite protracted and does not realize its full neurotoxic 
potential for up to 28 weeks after injection (Bjorklund et al., 1997); so, clearly it is just 
an early indicator of 6-OHDA toxicity to the medial forebrain bundle. 
 The secondary analysis of weight gain throughout the study suggests that all of 
the rats, regardless of group assignment, had the same trajectory of weight gain over 
the course of the study (Table 21, Figure 18).  The general weight gain trajectory in the 
present study was consistent with the Kretschmer et al (2005) study (Kretschmer et al., 
2005).  However, in the Kretschmer et al (2005) study, rats who exercised for 12 minutes 
daily reduced their body weight over time.  This did not happen in the present study.  
Presumably, the rats in the two groups with an exercise component (i.e., voluntary, 
forced) must have had a compensatory increase in food consumption to keep up with 
the increased metabolic demand from the exercise.  Likewise, it is likely that the two 
none exercise groups (i.e., control, sham) did not consume as much because the 
metabolic demand of sedentary behavior was not as high as the exercise groups.  
However, these assumptions are speculative as the amount of food and fluid intake was 
not observed or recorded.  All rats had access to standard laboratory chow ad libitum; 
so, it is logical that food intake may have been compensatory depending on the energy 
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expenditure and metabolic demand of their daily tasks.  The literature is not consistent 
on this point.  Kretschmer et al (2005) showed no compensatory food intake in 
exercised rats (Kretschmer et al., 2005); however, Levin and Dunn-Meynell (2004) found 
that food intake was increased in exercising rats and Peng et al (1980) found a 
compensatory increase in food intake with voluntary running (Levin & Dunn-Meynell, 
2004; Peng et al., 1980).  The Kretschmer et al (2005) study used a time limited 
swimming regimen, whereas, the Levin and Dunn-Meynell (2004) study used rats that 
had free access to a running wheel, much like the voluntary running regimen in the 
present study (Kretschmer et al., 2005; Levin & Dunn-Meynell, 2004).  Monitoring the 
weight gain was an important consideration in the design of the present study because 
if there were a significant differential pattern of growth of the animal in the different 
groups it could mean that the stereotaxic coordinates of the 6-OHDA injection may not 
have been in the same area of the medial forebrain bundle.  Considering the inherent 
variability of stereotactic injections and variability in the size and shape of head, another 
source of potential error (i.e., difference size of the animal) would have been a threat to 
the internal validity of the study.   
 
CONCLUSION 
 A 6-week preconditioning of forced and voluntary exercise did not afford 
neuroprotection to recently weaned, 6-OHDA-lesioned rats in terms of motor behavioral 
tests.  Voluntary exercising, which had a 10 fold increase in exercise dosing compared to 
forced exercising was not better in terms of protection from motor behavioral 
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asymmetry than forced exercise.  In addition, neither was better than a no exercise 
control.  These results are not consistent with the body of literature on neuroprotection 
and suggest that there is no consensus on the premise that exercise is neuroprotective.  
Since the present study casts some doubt on the role of exercise as a neuroprotective 
agent, further research is warranted. 
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CHAPTER 5 
SUMMARY, SIGNIFICANCE, AND FUTURE STUDIES 
 
The concept of neuroprotection in the neurodegenerative diseases (e.g., PD, 
Alzheimer’s disease (AD)) has been at the forefront of the research agenda for 
neuroscientists for decades.  It hinges on the theory that these neurodegenerative 
diseases have an onset later in life and that the disease course (i.e., neurodegeneration) 
could possibly be prevented or lessened by employing a treatment before the onset of 
the disease.  Many in the neurodegenerative research community have called the 
search for a viable neuroprotective agent the “holy grail” of research in PD and AD. 
Over the last few decades, PD researchers have investigated many putative 
neuroprotective agents with limited success.  Because PD is thought to cause attrition of 
dopaminergic neurons through oxidative stress, many of these attempts have focused 
on agents that have strong antioxidant properties (e.g., Coenzyme Q10, creatine) 
(LeWitt, 2006; Mounsey & Teismann, 2010).  Most of these studies met mild or 
unremarkable results; yet the search for neuroprotective agents continues.  This 
dissertation was yet another attempt on a promising neuroprotective treatment that is 
inexpensive, easy to implement, free from serious side effects, and has a multitude of 
other robust benefits to many systems of the body: exercise. 
The overarching premise of this dissertation was that exercise was 
neuroprotective in a rat of model of PD.  It was based on several studies from rodent PD 
models that all reported strong treatment effects from exercise in terms of motor 
protection and positive changes to the underlying dopaminergic pathways (Cohen et al., 
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2003; Howells et al., 2005; Tillerson et al., 2003; Tillerson et al., 2001).  Despite this fairly 
strong and consistent evidence from the literature, the results of the studies in this 
dissertation do no support these findings.  In fact, the findings of the present study cast 
doubt on the role of exercise as a neuroprotective agent.  From a clinical perspective, 
the results of this study are a disappointment for patients with PD and clinicians who 
treat patients with PD; however, they do suggest that more research is needed and this 
could potentially open up new lines of evidence about the underlying disease process of 
PD.  Clearly, the notion that exercise slows the neurodegeneration in PD is premature. 
When taking into account the differences in the designs of the three studies in 
this dissertation to those that this research was based on, it is clear that there were 
some small variations in design; however, they do not represent significant departures 
in dosing, duration, intensity and housing (Table 22).  Instead, an argument could be 
made that the designs in this dissertation were more rigorous from an exercise 
perspective than the majority of studies.  While it might be appropriate to dissect and 
scrutinize the differences between the studies, it is also important to understand that if 
exercise were truly neuroprotective, minor departures (mostly in the direction of 
increased dosing and intensity) should not negate the neuroprotective effects of 
exercise.  Thus, if exercise were truly neuroprotective as the body of literature suggests 
then increasing the exercise regimen should actually produce a more robust 
neuroprotective effect.  On the other hand, it could be argued that the differences in 
design and protocol may have introduced confounding effects that negated the 
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protection.  In either case, if exercise is truly neuroprotective then its positive protective 
effect should not be so fragile. 
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Table 22.  Design characteristics of the literature on neuroprotection in 6-OHDA models 
of Parkinson’s disease. 
Study Design Comparison Exercise dose 
Exercise 
duration  Other Housing 
Tajiri et 
al, 2010 Neuroplasticity Forced vs. control 
5 days/week 
30 min/day 
11 m/minute 
Post: 4 
weeks 
Exercise group 
had more BrdU 
+ cells in 
striatum 
Housed 
two per 
cage 
Tillerson 
et al, 
2003 
Neuroplasticity 
Forced vs. Sham 
control vs. lesion 
control 
Daily? 
30 min/day 
15m/minute 
Post: 4 
weeks 
Running 
occurred 
during the dark 
cycle 
 
Tillerson 
et al, 
2001 
Neuroplasticity 
Forced (3 start 
times) vs. Control 
vs. Sham (3 start 
times) 
Unimpaired 
forelimb casting 
Post: 1 
week?  
Housed in 
groups of 3 
Tillerson 
et al, 
2002 
Neuroplasticity 
Forced non-use 
vs. Sham vs. 
Control 
Impaired 
forelimb casting 
Post: 1 
week  
Housed in 
groups of 3 
O’Dell et 
al, 2007 
Neuroprotection 
and 
Neuroplasticity 
Forced+Voluntary 
vs. Control 
Pre: 10.5 
m/min 
30 min/day 
Running wheel 
Post: 6m/min 
30 min/day 
Running wheel 
Pre: 2.5 
weeks 
Post: 4 
weeks 
No 
preservation of 
dopamine 
terminals 
Most rats ran 
>1000 
meters/day 
Individually 
Cohen et 
al, 2003 Neuroprotection 
Forced vs. Sham 
vs. Control 
Impaired 
forelimb casting 
Pre: 1 
week  
Housed 
two per 
cage 
Mabandla 
et al, 
2004 
Neuroprotection 
and 
neuroprotection 
Voluntary vs. 
control 
Access to 
running wheel 
Pre: 1 
week 
Post: 2 
weeks 
Pre: 5388 
revolutions/day 
Post: 4361 
revolutions/day 
Individually 
Howells 
et al, 
2005 
Neuroprotection 
and 
neuroplasticity 
Stressed 
voluntary vs. 
Voluntary vs. 
Control 
Access to 
running wheel 
Pre: 1 
week 
Post: 2 
weeks 
Pre average 
distance: 2182 
meters/day 
Post: 2140 
meters/day 
Individually 
Aim 1 Neuroplasticity Forced vs. Control 
5 days/week 
30 min/day 
15 m/minute 
Post: 4 
weeks 
450 
meters/day Individually 
Aim 2 Neuroprotection Forced vs. Control 
5 days/week 
30 min/day 
15 m/minute 
Pre: 4 
weeks 
450 
meters/day Individually 
Aim 3 
Neuroprotection 
and 
neuroplasticity 
Forced vs. 
Voluntary vs. 
Sham control vs. 
Lesion control 
6 days/week 
30 min/day 
15 m/minute 
Pre: 6 
week 
Post: 1 
weeks 
Forced: 450 
meters/day 
Voluntary: 
3500 
meters/day 
Individually 
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As the dissertation evolved, three other premises emerged that helped guide the 
design of the study in Chapter 4.  First, a “true” neuroprotective design would 
implement exercise before the injection of the neurotoxin (i.e., before disease onset).  
However, the body of literature on the neuroprotective effect of exercise in PD has 
almost uniformly been implemented in animals after neurotoxic insult (Cohen et al., 
2003; Howells et al., 2005; Tillerson et al., 2003; Tillerson et al., 2001).  Technically, this 
is not “neuroprotection” in any sense but rather “neuroplasticity” or “neurorecovery” 
because the exercise was implemented after the onset of the disease.  While it has been 
convention to use the term “neuroprotection” in these studies, it is misleading.  There 
have been only a few studies that have used a true “neuroprotection” design, wherein 
an exercise program was administered prior to neurotoxic insult using PD rodent models 
(Cohen et al., 2003; Mabandla et al., 2004; O'Dell et al., 2007).  Therefore, Chapter 2 
was technically a “neuroplasticity” design and Chapters 3 and 4 were designed with 
“neuroprotection” in mind.  Since there are very few true “neuroprotective” designs 
with exercise and PD in the literature, Chapters 3 and 4 were fairly novel. 
Another important premise in the design of the study in Chapter 4 was that 
implementation of exercise in young, recently weaned rats would potentially produce 
more robust outcomes.  Using rats so young was also a novel design element as this has 
not been reported in the literature.  Almost all of the published studies on the effect of 
exercise on symptoms and neurobiology in rat PD models have used older rats.  The 
reasons for this are not entirely clear.  However, one prominent researcher in the field 
(Timothy Schallert, personal communication) suggested that younger rats are much 
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more tolerant to the toxin 6-OHDA the Parkinsonian behavioral symptoms.  While using 
older rats would make sense for a study that has incorporated a “neuroplasticity” design 
wherein the rats are exercised after neurotoxin-induced PD, it does not make sense in a 
“neuroprotection” design wherein rats are exercised before neurotoxin-induced PD.  
Unfortunately, neuroprotection studies in PD have almost uniformly used adult rats.  
This is akin to having humans start an exercise program later in life with the hopes that 
it will be protective.  Perhaps an important “window of opportunity” may have been 
missed by not starting exercise earlier during brain development.  While 
implementation of exercise in adult rats certainly makes sense from a neuroprotective 
perspective, these designs may not capture the true neuroprotective effect of exercise 
throughout the life of the animal as they were all administered to adult rats as was done 
in Chapter 3.  For this reason, the purpose of the study in Chapter 4 was to explore this 
potential window of opportunity by implementing exercise to recently weaned rat pups.  
Since it is conventionally thought that young rats are more resistant to the neurotoxin 6-
OHDA, the exercise period was lengthened to 6 weeks so that these recently weaned 
rats would be adults when they were injected with the neurotoxin.  If you consider the 
three studies in this dissertation, older adult rats (Chapters 2 and 3) had considerably 
more PD behavioral symptoms than the younger adult rats in Chapter 4.  While these 
results would support the assertion that was made by Timothy Schallert (personal 
communication), the overall findings of these studies suggest that exercise in either 
adult or recently weaned rats is not neuroprotective in terms of motor behavioral 
symptoms. 
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The third premise that emerged in this dissertation and helped guide the design 
of the study in Chapter 4 was that forced exercise, because of aversive conditioning (i.e., 
unpleasant encounters with an electrical grid at the back of the rodent treadmill), might 
not afford neuroprotection because it stressed the animal.  Stress has been implicated 
as a key factor of neurodegeneration in PD (Smith et al., 2002).  In addition, it has been 
shown to negate the neuroprotective effect of exercise in a rat model of PD (Howells et 
al., 2005).  In order to determine if exercise itself was neuroprotective a novel design 
would be necessary.  First, an additional exercise modality (i.e., voluntary exercise) was 
added to compare it to exercise within a stressful milieu (i.e., forced exercise).  If 
exercise was indeed neuroprotective and if stressed rats were less likely to benefit from 
this neuroprotection, then this design element would have allowed some inference into 
the true relationship between exercise and PD.  This was the first study to compare 
forced and voluntary exercise in the 6-OHDA model.  Unfortunately, the results of this 
study did not support exercise, either forced or voluntary, as a neuroprotective strategy 
in this model of PD. 
Other than the stress component of forced exercise, one of the key differences 
between voluntary and forced exercise in animal models is that voluntary exercise 
allows the animal flexibility in the timing and dosage of the exercise.  Based on the 
results of the study in Chapter 4, rats are capable of considerable amounts of running 
when they are left to run at their own discretion (Table 27, Figures 20-21).  This is in 
contrast to Leasure and Jones (2008) who found that rats in a forced exercise condition 
ran about the same distance as rats that voluntarily exercised; however, they also found 
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that voluntary exercise rats ran faster and for less total time than rats that were forced 
(Leasure & Jones, 2008).  Since forced and voluntary exercise are different on so many 
levels (i.e., dosing of exercise, time of day, aversion stimuli), it is an attractive area of 
comparison.  Leasure and Jones (2008) agree that comparing the neural and behavioral 
effects of different forms of exercise, like forced and voluntary exercise, needs more 
scientific attention (Leasure & Jones, 2008).  From an internal validity perspective, 
voluntary exercise is a more attractive modality for future exercise studies because it is 
free from potential confounding variables that plague forced exercise, like exercising in 
the less active cycle (i.e., light cycle), aversive stimuli (i.e., electrical shocks), and animal 
handling variations associated with transfer to and from the treadmill. 
One novel element of this dissertation was the analysis of exploratory rearing as 
a behavioral surrogate of hypokinesia, which is a paucity of movement or abnormally 
diminished motor activity.  It was felt that the number of times an animal would rear for 
exploration during a 10 minute time frame might possibly be an accurate indicator of 
this common, human PD symptom (Dunnewold et al., 1998; Hoshiyama et al., 1994; van 
Hilten et al., 1995; van Hilten et al., 1998).  Hypokinesia, observed in this way, has not 
previously been explored in the literature in rodent PD models.  Only one study has 
explored hypokinesia in 6-OHDA rats; however, they did so by measuring motor activity 
for one minute using a photocell activity apparatus in rats with bilateral 6-OHDA 
lesioning (Jolicoeur et al., 1991).  These researchers did find hypokinesia to be a 
prominent feature of the 6-OHDA symptom profile.  This lends validity to the use of 
exploratory rearing in this dissertation as a behavioral surrogate of hypokinesia.  
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Moreover, the collective findings in this dissertation of this motor test suggest that this 
test might be useful in future studies using the 6-OHDA model even in cases with only a 
unilateral neurotoxic injection. 
The results of this dissertation clearly show that exploratory rearing is a 
prominent feature of 6-OHDA lesioning.  In Chapter 2, exploratory rearing improved 
over time after 6-OHDA lesioning (Figure 7, Table 8).  In Chapter 3, exploratory rearing 
decreased immediately after the 6-OHDA lesion (Figure 12, Table 14).  In Chapter 4, 
exploratory rearing was significantly higher in the sham lesion group compared to the 
three groups that had the 6-OHDA lesion (Table 19, Figure 17).  In addition, in Chapters 
3 and 4, exploratory rearing was significantly correlated to two of the most commonly 
used behavioral tests in rat PD model research, apomorphine rotations and forelimb 
placement asymmetry (Tables 15 and 20).  Taken together, these results lend validity to 
exploratory rearing as a useful assessment tool for hypokinetic behavior in rat models of 
PD. 
Another novel observation in this study was the presence of an immediate right 
neck turn after 6-OHDA lesioning before the animal had regained full consciousness.  
This was transient and went away after an hour or so.  This has not been documented in 
the literature.  During the first study (Chapter 2), it seemed that many of the rats had a 
right neck turn within about 10 minutes after surgery (Figure 22).  Since all of the rats 
had a 6-OHDA injection into the region of the right medial forebrain bundle, it was 
logical that this right neck turn could be related to the surgery.  From a neurophysiologic 
perspective, this might suggest that the neurotoxin is immediately taken up by 
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nigrostriatal fibers destined for the right striatum.  Because the right striatum reinforces 
motor facilitation in the contralateral half of the body, toxic insult to this pathway would 
logically cause a decrease in striatal-reinforced motor facilitation in the left side of the 
animal, including the neck sidebending musculature that would cause the neck to move 
to the left.   Concomitantly, a decrease in muscular facilitation on the left would be met 
by a relative increase in motor facilitation on the right causing the right neck turn.  Over 
time, the animal, when fully conscious, would be able to make corrective centering of 
the head during routine behavioral activities and, thus, would be able to overcome the 
imbalanced motor facilitation through volitional control. 
It was felt that the immediate but transient right neck turn could possibly be an 
early indicator of successful neurotoxin placement into the right medial forebrain 
bundle.  Since some of the rats did not have this right neck turn, it was thought that 
perhaps the stereotactic injection of the neurotoxin did not reach its mark.  Since this 
was just a theory, observation of it was standardized in Chapters 3 and 4.  In Chapter 3, 
moderate to strong correlations were found with this immediate postoperative 
observation to apomorphine rotations, forelimb placement asymmetry and exploratory 
rearing (point biserials = 0.734, 0.534, and -0.749, respectively).  Thus, this immediate 
right neck turn was indeed related to the severity of the Parkinsonian behavioral 
asymmetries.  Moderate correlations, consistent with Chapter 3 results, were also 
observed in Chapter 4.  Taken together, the immediate observation of postoperative 
right neck turn is an early sign of successful neurotoxin injection into the medial 
forebrain bundle.  While it is a fairly well-established fact that 6-OHDA has a protracted 
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neurotoxicity (Bjorklund et al., 1997), based on the results of the studies in this 
dissertation, 6-OHDA has in the least an immediate neurotoxic effect on motor 
facilitation. 
There were several limitations in the design of this dissertation that may have 
influenced the results.  First, the experimental control of the designs could have been 
improved.  For instance, all of the rats should be exposed to the same time, type and 
duration of handling procedures and other design related variations regardless of 
experimental group.  Consider the design of Chapter 4.  The voluntary rats were housed 
in different housing units than the other rats (i.e., housing units with free access to an 
attached running wheel).  Also, the forced rats were handled twice daily during their 
forced running protocol.  The voluntary, sham and control rats were not handled at all 
except for weighing and cleaning housing units.  Ideally, every rat should have been 
housed in the same type of housing unit; the housing unit with the running wheel would 
have been ideal for all of the rats in all of the conditions.  However, in the conditions 
were there were no running expectations then the wheel could have been immobilized.  
In addition, all of the rats should have been exposed to the running treadmill with the 
same frequency and duration as the forced runners; however, the treadmill belt would 
not have been turned on for the other conditions.  Second, housing the rats individually 
could have been a potential stressful confounding factor.  Rats could have been housed 
in groups and then, in the case of the voluntary exercise, radiofrequency identification 
technology could have been utilized to identify which rats were running, how long, and 
how intense.  Third, rats should be exercised during their more active cycle (i.e., the 
108 
 
dark cycle).  Since the rats in the voluntary exercise clearly exercised more during the 
dark cycle it would stand to reason that the forced exercise should have taken place 
during that same time. 
Future designs investigating the effects of exercise in rodent model of PD should 
consider some of the new transgenic and knockout models (i.e., rat and mouse) that 
have recently emerged on the market.  The majority of these mostly untested models 
were not available at the time of this dissertation; however, they represent an 
important development in rodent PD models and might afford a closer approximation to 
human PD.  In addition, rather than using a bolus delivery protocol for neurotoxin, as 
was done in this dissertation, researchers should consider a slower delivery method 
(e.g., Alzet pumps) to more closely approximate the slow, progressive 
neurodegeneration seen in human PD (Alvarez-Fischer et al., 2008). 
In summary, the results of the studies in this dissertation cast doubt on the 
neuroprotective properties of voluntary and forced exercise in a 6-OHDA-induced 
hemiparkinsonian model.  Since the findings of this dissertation are clearly in contrast to 
the body of literature on this topic, there is a need to further develop these hypotheses 
using more rigorous designs.  In the least, the results of this dissertation should add 
some caution to the commonly held assumption in the neurodegenerative community 
that exercise is neuroprotective in rat models of PD. 
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